Globalstar (GSAT) 10-Q 3 Aug 17 2017 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2017	Jul. 28, 2017
Document and Entity Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2017
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q2
Trading Symbol	GSAT
Entity Registrant Name	Globalstar, Inc.
Entity Central Index Key	1,366,868
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Voting Common Stock
Document and Entity Information [Line Items]
Entity common stock, shares outstanding (in shares)		1,025,397,826
Nonvoting Common Stock
Document and Entity Information [Line Items]
Entity common stock, shares outstanding (in shares)		134,008,656

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Revenue:
Service revenues	$ 24,301	$ 20,970	$ 45,782	$ 39,719
Subscriber equipment sales	3,822	4,116	6,993	7,203
Total revenue	28,123	25,086	52,775	46,922
Operating expenses:
Cost of services (exclusive of depreciation, amortization, and accretion shown separately below)	9,036	7,937	18,010	15,528
Cost of subscriber equipment sales	2,778	2,886	4,874	5,064
Marketing, general and administrative	9,544	11,450	19,034	20,060
Depreciation, amortization and accretion	19,275	19,224	38,569	38,379
Total operating expenses	40,633	41,497	80,487	79,031
Loss from operations	(12,510)	(16,411)	(27,712)	(32,109)
Other income (expense):
Gain (loss) on equity issuance	1,964	(2,075)	2,670	(1,923)
Interest income and expense, net of amounts capitalized	(8,850)	(9,049)	(17,678)	(18,154)
Derivative gain (loss)	(77,130)	40,499	(73,907)	39,155
Other	(2,102)	685	(2,126)	(76)
Total other income (expense)	(86,118)	30,060	(91,041)	19,002
Income (loss) before income taxes	(98,628)	13,649	(118,753)	(13,107)
Income tax expense (benefit)	106	(450)	142	(259)
Net income (loss)	(98,734)	14,099	(118,895)	(12,848)
Other comprehensive income (loss):
Foreign currency translation adjustments	(45)	(925)	(865)	(1,576)
Total comprehensive income (loss)	$ (98,779)	$ 13,174	$ (119,760)	$ (14,424)
Net income (loss) per common share:
Basic (USD per share)	$ (0.09)	$ 0.01	$ (0.11)	$ (0.01)
Diluted (USD per share)	$ (0.09)	$ 0.01	$ (0.11)	$ (0.01)
Weighted-average shares outstanding:
Basic (in shares)	1,128,985	1,049,381	1,121,518	1,045,205
Diluted (in shares)	1,128,985	1,249,672	1,121,518	1,045,205

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2017	Dec. 31, 2016
Current assets:
Cash and cash equivalents	$ 8,838	$ 10,230
Accounts receivable, net of allowance of $4,116 and $3,966, respectively	15,369	15,219
Inventory	8,814	8,093
Prepaid expenses and other current assets	5,189	4,588
Total current assets	38,210	38,130
Property and equipment, net	1,013,798	1,039,719
Restricted cash	37,915	37,983
Intangible and other assets, net of accumulated amortization of $7,137 and $7,021, respectively	20,046	16,782
Total assets	1,109,969	1,132,614
Current liabilities:
Current portion of long-term debt	108,720	75,755
Debt restructuring fees	0	20,795
Accounts payable	7,624	7,499
Accrued contract termination charge	20,026	18,451
Accrued expenses	20,664	23,162
Derivative liabilities	36,860	0
Payables to affiliates	304	309
Deferred revenue	29,476	26,479
Total current liabilities	223,674	172,450
Long-term debt, less current portion	459,966	500,524
Employee benefit obligations	4,944	4,883
Derivative liabilities	318,215	281,171
Deferred revenue	5,866	5,877
Other non-current liabilities	5,830	5,890
Total non-current liabilities	794,821	798,345
Commitments and contingencies (Note 6)
Stockholders’ equity:
Preferred Stock	0	0
Additional paid-in capital	1,698,724	1,649,315
Accumulated other comprehensive loss	(6,243)	(5,378)
Retained deficit	(1,601,123)	(1,482,228)
Total stockholders’ equity	91,474	161,819
Total liabilities and stockholders’ equity	1,109,969	1,132,614
Series A preferred stock
Stockholders’ equity:
Preferred Stock	0	0
Common stock
Stockholders’ equity:
Common Stock	103	97
Nonvoting Common Stock
Stockholders’ equity:
Common Stock	$ 13	$ 13

Condensed Consolidated Balance4

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Jun. 30, 2017	Dec. 31, 2016
Accounts receivable, allowance	$ 4,116	$ 3,966
Accumulated amortization	$ 7,137	$ 7,021
Preferred stock, par value (USD per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	100,000,000	100,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Series A preferred stock
Preferred stock, par value (USD per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	1	1
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock
Common stock, par value (USD per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	1,500,000,000	1,200,000,000
Common stock, shares issued (in shares)	1,025,388,954	972,602,824
Common stock, shares outstanding (in shares)	1,025,388,954	972,602,824
Nonvoting Common Stock
Common stock, par value (USD per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	400,000,000	400,000,000
Common stock, shares issued (in shares)	134,008,656	134,008,656
Common stock, shares outstanding (in shares)	134,008,656	134,008,656

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Cash Flows $ in Thousands, BRL in Millions	6 Months Ended
	Jun. 30, 2017USD ($)	Jun. 30, 2016USD ($)
Cash flows provided by (used in) operating activities:
Net loss	$ (118,895)	$ (12,848)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation, amortization and accretion	38,569	38,379
Change in fair value of derivative assets and liabilities	73,907	(39,155)
Stock-based compensation expense	2,488	1,848
Amortization of deferred financing costs	4,158	4,672
Provision for bad debts	808	396
Noncash interest and accretion expense	5,688	5,487
Change in fair value related to equity issuance	(2,670)	1,923
Noncash expense related to legal settlement	0	1,094
Unrealized foreign currency (gain) loss	1,571	(77)
Other, net	660	262
Changes in operating assets and liabilities:
Accounts receivable	(823)	(2,144)
Inventory	(622)	2,924
Prepaid expenses and other current assets	(990)	(868)
Other assets	(792)	104
Accounts payable and accrued expenses	529	(1,474)
Payables to affiliates	(5)	(377)
Other non-current liabilities	24	50
Deferred revenue	2,651	805
Net cash provided by operating activities	6,256	1,001
Cash flows used in investing activities:
Second-generation network costs (including interest)	(6,530)	(5,307)
Property and equipment additions	(2,116)	(6,345)
Purchase of intangible assets	(2,044)	(806)
Net cash used in investing activities	(10,690)	(12,458)
Cash flows provided by (used in) financing activities:
Principal payments of the Facility Agreement	(21,695)	(16,418)
Proceeds from Thermo Common Stock Purchase Agreement	33,000	0
Payment of debt restructuring fee	(20,795)	0
Payment of debt amendment fee	(255)	0
Proceeds from issuance of stock to Terrapin	12,000	28,500
Proceeds from issuance of common stock and exercise of options and warrants	635	3,016
Net cash provided by financing activities	2,890	15,098
Effect of exchange rate changes on cash	84	152
Net increase (decrease) in cash, cash equivalents and restricted cash	(1,460)	3,793
Cash, cash equivalents and restricted cash, beginning of period	48,213	45,394
Cash, cash equivalents and restricted cash, end of period	46,753	49,187
Reconciliation of cash, cash equivalents and restricted cash
Total cash, cash equivalents and restricted cash shown in the statement of cash flows	48,213	45,394
Cash paid for interest
Interest	11,659	10,922
Supplemental disclosure of non-cash financing and investing activities:
Increase in capitalized accrued interest for second-generation network costs	2,003	1,500
Capitalized accretion of debt discount and amortization of prepaid financing costs	2,510	2,099
Issuance of common stock for legal settlement	$ 453	$ 0

Basis of Presentation

Basis of Presentation	6 Months Ended
	Jun. 30, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	1. BASIS OF PRESENTATION Globalstar, Inc. (“Globalstar” or the “Company”) provides Mobile Satellite Services (“MSS”) including voice and data communications services through its global satellite network. Thermo Capital Partners LLC, through its affiliates (collectively, “Thermo”), is the principal owner and largest stockholder of Globalstar. The Company’s Chairman and Chief Executive Officer controls Thermo. Two other members of the Company's Board of Directors are also directors, officers or minority equity owners of various Thermo entities. The Company has prepared the accompanying unaudited interim condensed consolidated financial statements in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) for interim financial information. Certain information and footnote disclosures normally in financial statements have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission (the "SEC"); however, management believes the disclosures made are adequate to make the information presented not misleading. These financial statements and notes should be read in conjunction with the consolidated financial statements and notes thereto included in the Globalstar Annual Report on Form 10-K for the year ended December 31, 2016 , as filed with the SEC on February 23, 2017 (the "2016 Annual Report"), and Management's Discussion and Analysis of Financial Condition and Results of Operations herein. The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from estimates. The Company evaluates estimates on an ongoing basis. Significant estimates include the value of derivative instruments, the allowance for doubtful accounts, the net realizable value of inventory, the useful life and value of property and equipment, the value of stock-based compensation and income taxes. The Company has made certain reclassifications to prior period condensed consolidated financial statements to conform to current period presentation. These unaudited interim condensed consolidated financial statements include the accounts of Globalstar and all its subsidiaries. All significant intercompany transactions and balances have been eliminated in the consolidation. In the opinion of management, the information included herein includes all adjustments, consisting of normal recurring adjustments, that are necessary for a fair presentation of the Company’s condensed consolidated statements of operations, condensed consolidated balance sheets, and condensed consolidated statements of cash flows for the periods presented. The results of operations for the three and six months ended June 30, 2017 are not necessarily indicative of the results that may be expected for the full year or any future period. Recently Issued Accounting Pronouncements In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Updates ("ASU") No. 2014-09, Revenue from Contracts with Customers . ASU 2014-09 has been modified multiple times since its initial release. This ASU outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. ASU 2014-09, as amended, becomes effective for annual reporting periods beginning after December 15, 2017. Early adoption is permitted; however, the Company plans on adopting this standard when it becomes effective on January 1, 2018. The Company has an internal project team that is evaluating the impact this standard will have on its financial statements, accounting systems and related disclosures. Currently, the Company expects that the most significant changes to the Company's revenue recognition accounting policies will be related to the following: 1) the allocation and timing of revenue recognized between service revenue and subscriber equipment sales, 2) the timing of service revenue recognized for breakage during certain customer's prepaid contracts and 3) the deferment of certain contract acquisition costs and the recognition of these costs over the expected life of a customer's contract. The standard permits the use of either the retrospective or cumulative effect transition method. The Company expects to follow the cumulative effect method of adoption. In March 2016, the FASB issued ASU No. 2016-02, Leases . The main difference between the provisions of ASU No. 2016-02 and previous U.S. GAAP is the recognition of right-of-use assets and lease liabilities by lessees for those leases classified as operating leases under previous U.S. GAAP. ASU No. 2016-02 retains a distinction between finance leases and operating leases, and the recognition, measurement, and presentation of expenses and cash flows arising from a lease by a lessee have not significantly changed from previous U.S. GAAP. For leases with a term of 12 months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize right-of-use assets and lease liabilities. The accounting applied by a lessor is largely unchanged from that applied under previous U.S. GAAP. In transition, lessees and lessors are required to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach. This ASU is effective for public business entities in fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. Early adoption is permitted as of the beginning of any interim or annual reporting period. The Company is currently evaluating the impact this standard will have on its financial statements and related disclosures. In June 2016, the FASB issued ASU No. 2016-13, Credit Losses, Measurement of Credit Losses on Financial Instruments . ASU No. 2016-13 significantly changes how entities will measure credit losses for most financial assets and certain other instruments that are not measured at fair value through net income. The standard will replace today’s incurred loss approach with an expected loss model for instruments measured at amortized cost. Entities will apply the standard’s provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. This ASU is effective for public entities for annual and interim periods beginning after December 15, 2019. Early adoption is permitted for all entities for annual periods beginning after December 15, 2018, and interim periods therein. The Company has not yet determined the impact this standard will have on its financial statements and related disclosures. In January 2017, the FASB issued ASU No. 2017-01, Business Combinations: Clarifying the Definition of a Business . ASU 2017-01 most significantly revises guidance specific to the definition of a business related to accounting for acquisitions. Additionally, ASU 2017-01 also affects other areas of US GAAP, such as the definition of a business related to the consolidation of variable interest entities, the consolidation of a subsidiary or group of assets, components of an operating segment, and disposals of reporting units and the impact on goodwill. This ASU is effective for public entities for annual and interim periods beginning after December 15, 2017. Early adoption is permitted as of the beginning of any interim or annual reporting period. The Company does not expect it to have a material effect on the Company's condensed consolidated financial statements and related disclosures. In February 2017, the FASB issued ASU 2017-05, Other Income—Gains and Losses from the Derecognition of Nonfinancial Assets: Clarifying the Scope of Asset Derecognition Guidance and Accounting for Partial Sales of Nonfinancial Assets . ASU 2017-06 was issued to provide clarity on the scope and application for recognizing gains and losses from the sale or transfer of nonfinancial assets, and should be adopted concurrently with ASU 2014-09: Revenue from Contracts with Customers . This ASU is effective for public entities for annual and interim periods beginning after December 15, 2017. Early adoption is permitted as of the beginning of any interim or annual reporting period. The Company is currently evaluating the impact this standard will have on its financial statements and related disclosures. In February 2017, the FASB issued ASU 2017-07: Compensation—Retirement Benefits: Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost . ASU 2017-07 requires sponsors of benefit plans to present the service cost component of net periodic benefit cost in the same income statement line or items as other employee costs and present the remaining components of net periodic benefit cost in one or more separate line items outside of income from operations. This ASU also limits the capitalization of benefit costs to only the service cost component. This ASU is effective for public entities for annual and interim periods beginning after December 15, 2017. Early adoption is permitted as of the beginning of any interim or annual reporting period. The Company does not expect it to have a material effect on the Company's condensed consolidated financial statements and related disclosures. In March 2017, the FASB issued ASU 2017-08: Receivables—Nonrefundable Fees and Other Costs: Premium Amortization on Purchased Callable Debt Securities . This ASU amends current US GAAP to shorten the amortization period for certain purchased callable debt securities held at a premium to the earliest call date. This ASU is effective for public entities for annual and interim periods beginning after December 15, 2018. Early adoption is permitted as of the beginning of any interim or annual reporting period. The Company does not expect it to have a material effect on the Company's condensed consolidated financial statements and related disclosures. In May 2017, the FASB issued ASU 2017-09: Compensation—Stock Compensation: Scope of Modification Accounting. This ASU clarifies when changes to the terms or conditions of a share-based payment award must be accounted for as modifications. Under the new guidance, a company will apply modification accounting only if the fair value, vesting conditions or classification of the award change due to a modification in the terms or conditions of the share-based payment award. This ASU is effective for public entities for annual and interim periods beginning after December 15, 2017. Early adoption is permitted as of the beginning of any interim or annual reporting period. The Company does not expect it to have a material effect on the Company's condensed consolidated financial statements and related disclosures. In July 2017, the FASB issued ASU 2017-11: I. Accounting for Certain Financial Instruments With Down Round Features and II. Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests With a Scope Exception. Part I of this ASU reduces the complexity associated with accounting for certain financial instruments with down round features. Part II of this ASU recharacterizes the indefinite deferral provisions described in Topic 480: Distinguishing Liabilities from Equity. It does not have an accounting effect. This ASU is effective for public entities for annual and interim periods beginning after December 15, 2018. Early adoption is permitted as of the beginning of any interim or annual reporting period. The Company is currently evaluating the impact this standard will have on its financial statements and related disclosures. Recently Adopted Accounting Pronouncements In November 2016, the FASB issued ASU No. 2016-18, Statement of Cash Flows - Restricted Cash . ASU 2016-18 requires entities to show the changes in the total of cash, cash equivalents, restricted cash and restricted cash equivalents in the statement of cash flows. When cash, cash equivalents, restricted cash and restricted cash equivalents are presented in more than one line item on the balance sheet, a reconciliation of the totals in the statement of cash flows to the related captions in the balance sheet is required. This ASU is effective for public entities for annual and interim periods beginning after December 15, 2017. Early adoption is permitted as of the beginning of any interim or annual reporting period. The Company adopted this standard effective with reporting periods beginning on January 1, 2017 and reflected the impact of this standard using a retrospective transition method for each period presented. Additionally, the Company added required disclosures pursuant to ASC 2016-18 to its condensed consolidated statements of cash flows.

Property and Equipment

Property and Equipment	6 Months Ended
	Jun. 30, 2017
Property, Plant and Equipment [Abstract]
Property and Equipment	2. PROPERTY AND EQUIPMENT Property and equipment consists of the following (in thousands): June 30, December 31, Globalstar System: Space component First and second-generation satellites in service $ 1,195,180 $ 1,211,090 Prepaid long-lead items 17,040 17,040 Second-generation satellite, on-ground spare 32,481 32,481 Ground component 48,562 48,400 Construction in progress: Space component 463 81 Ground component 217,199 207,127 Next-generation software upgrades 11,091 10,223 Other 1,917 2,299 Total Globalstar System 1,523,933 1,528,741 Internally developed and purchased software 16,530 15,005 Equipment 10,153 9,875 Land and buildings 3,319 3,330 Leasehold improvements 1,940 1,893 Total property and equipment 1,555,875 1,558,844 Accumulated depreciation (542,077 ) (519,125 ) Total property and equipment, net $ 1,013,798 $ 1,039,719 Amounts in the above table consist primarily of costs incurred related to the construction of the Company’s second-generation constellation and ground upgrades. The ground component of construction in progress represents costs (including capitalized interest) associated with the Company's contracts with Hughes Network Systems, LLC ("Hughes") and Ericsson Inc. (“Ericsson”) related to the second-generation upgrades to the Company's ground infrastructure. The Company will begin depreciating this asset when the second-generation gateways are placed into commercial service. See Note 6: Commitments and Contingencies for further discussion of these contracts. Amounts included in the Company’s second-generation satellite, on-ground spare balance as of June 30, 2017 consist primarily of costs related to a spare second-generation satellite that has not been placed in orbit, but is capable of being included in a future launch. As of June 30, 2017 , this satellite and the prepaid long-lead items ("LLI") have not been placed into service; therefore, the Company has not started to record depreciation expense for these items. Pursuant to the Amended and Restated Contract for the construction of Globalstar Satellites for the Second Generation Constellation between the Company and Thales Alenia Space France ("Thales"), dated and executed in June 2009 (the "2009 Contract"), the Company paid €12 million in purchase price plus an additional €3.1 million in procurement costs for the LLI to be procured by Thales on the Company's behalf. The LLI were to be used in the construction of the Phase 3 satellites for the Company. As reflected on the Company's condensed consolidated balance sheets and in the above table, the Company believes that it owns the LLI and that title to the LLI transferred to the Company upon payment. The Company has asked Thales to turn over the LLI. Despite historical statements to the contrary, Thales currently disputes the Company's ownership of the LLI and has asserted that the Company released its title to the LLI pursuant to that certain Release Agreement, dated as of June 24, 2012, which is described more fully in Note 6: Commitments and Contingencies . Thales further asserts that the LLI belong to Thales and that Thales has no obligation to turn over possession of the LLI to the Company. The Company disputes Thales' assertions and is considering its rights and remedies to recover the LLI. At this time, the Company cannot predict the outcome related to this dispute, including, without limitation, the likelihood of any settlement or the probability of success with respect to any litigation that the Company may determine to commence with respect to the LLI.

Long-Term Debt and Other Financ

Long-Term Debt and Other Financing Arrangements	6 Months Ended
	Jun. 30, 2017
Debt Disclosure [Abstract]
Long-Term Debt and Other Financing Arrangements	3. LONG-TERM DEBT AND OTHER FINANCING ARRANGEMENTS Long-term debt consists of the following (in thousands): June 30, 2017 December 31, 2016 Principal Amount Unamortized Discount and Deferred Financing Costs Carrying Value Principal Amount Unamortized Discount and Deferred Financing Costs Carrying Value Facility Agreement $ 521,317 $ 40,098 $ 481,219 $ 543,011 $ 45,651 $ 497,360 Thermo Loan Agreement 99,776 28,035 71,741 93,962 29,615 64,347 8.00% Convertible Senior Notes Issued in 2013 17,319 1,593 15,726 17,126 2,554 14,572 Total Debt 638,412 69,726 568,686 654,099 77,820 576,279 Less: Current Portion 110,313 1,593 108,720 75,755 — 75,755 Long-Term Debt $ 528,099 $ 68,133 $ 459,966 $ 578,344 $ 77,820 $ 500,524 The principal amounts shown above include payment of in-kind interest, as applicable. The carrying value is net of deferred financing costs and any discounts to the loan amounts at issuance, including accretion, as further described below. The current portion of long-term debt represents the scheduled principal repayments under the Facility Agreement due within one year of the balance sheet date and the total outstanding balance of the Company's 2013 8.00% Notes (as defined below) as the first put date of the notes is April 1, 2018. These short-term debt obligations are significant and the Company believes these obligations will be in excess of its cash flows from operations. The Company intends to raise funds in sufficient amounts to make these payments; however, the source of funds has not yet been fully arranged. Facility Agreement In 2009, the Company entered into the Facility Agreement with a syndicate of bank lenders, including BNP Paribas, Société Générale, Natixis, Crédit Agricole Corporate and Investment Bank (formerly Calyon) and Crédit Industriel et Commercial, as arrangers, and BNP Paribas, as the security agent. The Facility Agreement was amended and restated in July 2013, August 2015 and June 2017. The Facility Agreement is scheduled to mature in December 2022 . As of June 30, 2017 , the Facility Agreement was fully drawn. Semi-annual principal repayments began in December 2014. Indebtedness under the facility bears interest at a floating rate of LIBOR plus 2.75% through June 2017, increasing by an additional 0.5% each year thereafter to a maximum rate of LIBOR plus 5.75% . Interest on the Facility Agreement is payable semi-annually in arrears on June 30 and December 31 of each calendar year. Ninety-five percent of the Company’s obligations under the Facility Agreement are guaranteed by Bpifrance Assurance Export S.A.S. ("BPIFAE") (formerly COFACE), the French export credit agency. The Company’s obligations under the Facility Agreement are guaranteed on a senior secured basis by all of its domestic subsidiaries and are secured by a first priority lien on substantially all of the assets of the Company and its domestic subsidiaries (other than their FCC licenses), including patents and trademarks, 100% of the equity of the Company’s domestic subsidiaries and 65% of the equity of certain foreign subsidiaries. The Facility Agreement contains customary events of default and requires that the Company satisfy various financial and non-financial covenants. The covenants in the Facility Agreement limit the Company's ability to, among other things, incur or guarantee additional indebtedness; make certain investments, acquisitions or capital expenditures above certain agreed levels; pay dividends or repurchase or redeem capital stock or subordinated indebtedness; grant liens on its assets; incur restrictions on the ability of its subsidiaries to pay dividends or to make other payments to the Company; enter into transactions with its affiliates; merge or consolidate with other entities or transfer all or substantially all of its assets; and transfer or sell assets. In calculating compliance with the financial covenants of the Facility Agreement, the Company may include certain cash funds contributed to the Company from the issuance of the Company's common stock and/or subordinated indebtedness. These funds are referred to as "Equity Cure Contributions" and may be used to achieve compliance with financial covenants through December 2019. If the Company violates any covenants and is unable to obtain a sufficient Equity Cure Contribution or obtain a waiver, or is unable to make payments to satisfy its debt obligations under the Facility Agreement and is unable to obtain a waiver, it would be in default under the Facility Agreement and payment of the indebtedness could be accelerated. The acceleration of the Company's indebtedness under one agreement may permit acceleration of indebtedness under other agreements that contain cross-acceleration provisions. As of June 30, 2017 , the Company was in compliance with respect to the covenants of the Facility Agreement. The Facility Agreement also requires the Company to maintain a debt service reserve account, which is pledged to secure all of the Company's obligations under the Facility Agreement. The use of these funds is restricted to making principal and interest payments under the Facility Agreement. Prior to October 30, 2017, the Company must maintain a total of $37.9 million in a debt service reserve account. On October 30, 2017, the balance in the debt service reserve account must equal the total amount of principal and interest payable by the Company on the next payment date. As of June 30, 2017 , the balance in the debt service reserve account was $37.9 million and classified as restricted cash on the Company's condensed consolidated balance sheets. On June 30, 2017, the Company, Thermo, the lenders and the BPIFAE and Security Agent entered into a Third Global Amendment and Restatement Agreement (the “2017 GARA”). Pursuant to the 2017 GARA, the Facility Agreement was amended and restated and the Company, Thermo and the lenders agreed to the following: • The amendments to the Facility Agreement defer most financial covenants until the measurement period ending December 31, 2018; extend to the measurement period ending December 31, 2019 the date through which Equity Cure Contributions can be made; eliminate the requirement of the Company to redeem in full the 2013 8.00% Notes (as defined below); defer mandatory prepayments from qualifying equity raises until January 1, 2020; and revise the definition of the debt service reserve account required balance after October 30, 2017 to mean an amount equal to the Debt Service (as defined in the 2017 GARA) amount due on the next payment date. • The Company agreed to raise at least $159.0 million in equity, which includes $12.0 million previously raised from its common stock purchase agreement with Terrapin Opportunity, L.P. ("Terrapin") in January 2017. The Company was required to raise a portion of the total $159.0 million by June 30, 2017 and the remaining amount no later than October 30, 2017. The Company was required to raise approximately $33.0 million as of June 30, 2017, which included amounts for the Company's outstanding restructuring fees, insurance premiums to BPIFAE and principal and interest due under the Facility Agreement as of June 30, 2017. If the Company does not raise the remaining funds by October 30, 2017, it would constitute an event of default under the Facility Agreement. The Company is required to deposit 80% of any equity proceeds raised through December 31, 2019 (including those funds required to be raised in 2017) into a restricted account, separate from the debt service reserve account discussed above, that may only be used to pay obligations under the Facility Agreement. • The 2017 GARA required Thermo to fund or backstop the amounts required to be raised as of June 30, 2017. The total $33.0 million was raised pursuant to the Common Stock Purchase Agreement with Thermo, discussed further below. • The Company agreed to limit capital expenditures in connection with its spectrum rights to be the lesser of (1) $20.0 million and (2) 20% of the proceeds of the aggregate of any equity the Company raises from January 1, 2017 through December 31, 2019. • The Company agreed to pay an amendment fee to the agent and lenders in the aggregate amount of $255,000 and accelerated the payment of the restructuring fee and insurance premium of approximately $20.8 million , which was previously due December 31, 2017 and accrued as a current liability on the Company's condensed consolidated balance sheet. The amendment and restatement of the Facility Agreement was considered a debt modification pursuant to applicable accounting guidance. As such, fees paid to the creditors were capitalized on the Company's condensed consolidated balance sheet as deferred financing costs and fees paid to the Company's advisors and other third parties were expensed in the Company's statement of operations for the period ended June 30, 2017. Thermo Loan Agreement In connection with the amendment and restatement of the Facility Agreement in July 2013, the Company amended and restated its loan agreement with Thermo (the “Loan Agreement”). All obligations of the Company to Thermo under the Loan Agreement are subordinated to the Company’s obligations under the Facility Agreement. The Loan Agreement accrues interest at 12% per annum, which is capitalized and added to the outstanding principal in lieu of cash payments. The Company will make payments to Thermo only when permitted by the Facility Agreement. Principal and interest under the Loan Agreement become due and payable six months after the obligations under the Facility Agreement have been paid in full, or earlier if the Company has a change in control or if any acceleration of the maturity of the loans under the Facility Agreement occurs. As of June 30, 2017 , $56.3 million of interest had accrued since 2009 with respect to the Loan Agreement; the Loan Agreement is included in long-term debt on the Company’s condensed consolidated balance sheets. The Company evaluated the various embedded derivatives within the Loan Agreement (See Note 5: Fair Value Measurements for additional information about the embedded derivative in the Loan Agreement). The Company determined that the conversion option and the contingent put feature upon a fundamental change required bifurcation from the Loan Agreement. The conversion option and the contingent put feature were not deemed clearly and closely related to the Loan Agreement and were separately accounted for as a standalone derivative. The Company recorded this compound embedded derivative liability as a non-current liability on its condensed consolidated balance sheets with a corresponding debt discount, which is netted against the face value of the Loan Agreement. The Company is accreting the debt discount associated with the compound embedded derivative liability to interest expense through the maturity of the Loan Agreement using an effective interest rate method. The fair value of the compound embedded derivative liability is marked-to-market at the end of each reporting period, with any changes in value reported in the condensed consolidated statements of operations. The Company determines the fair value of the compound embedded derivative using a blend of a Monte Carlo simulation model and market prices. The amount by which the if-converted value of the Thermo Loan Agreement exceeds the principal amount at June 30, 2017 , assuming conversion at the closing price of the Company's common stock on that date of $2.13 per share, is approximately $190.7 million . As discussed above, in connection with the 2017 GARA, Thermo and certain of its affiliates agreed to fund or backstop approximately $33.0 million in funding to the Company by June 30, 2017. The total amount was raised pursuant to the Common Stock Purchase Agreement entered into between the Company and Thermo on June 30, 2017. According to the terms of the Common Stock Purchase Agreement, Thermo purchased 17.8 million shares of the Company's voting common stock for $33.0 million at a purchase price of $1.85 , which represented a 10% discount to the closing price of the Company's voting common stock on June 29, 2017. The terms of the Common Stock Purchase Agreement were approved by a special committee of independent directors of the Board of Directors, who were represented by independent legal counsel. 8.00% Convertible Senior Notes Issued in 2013 The 8.00% Convertible Senior Notes Issued in 2013 (the "2013 8.00% Notes") are convertible into shares of common stock at a conversion price of $0.73 (as adjusted) per share of common stock. The conversion price of the 2013 8.00% Notes is adjusted in the event of certain stock splits or extraordinary share distributions, or as a reset of the base conversion and exercise price pursuant to the terms of the Fourth Supplemental Indenture between the Company and U.S. Bank National Association, as Trustee, dated May 20, 2013 (the "Indenture"). The 2013 8.00% Notes are senior unsecured debt obligations of the Company with no sinking fund. The 2013 8.00% Notes will mature on April 1, 2028, subject to various call and put features, and bear interest at a rate of 8.00% per annum. Interest on the 2013 8.00% Notes is payable semi-annually in arrears on April 1 and October 1 of each year. Interest is paid in cash at a rate of 5.75% per annum and in additional notes at a rate of 2.25% per annum. The Indenture for the 2013 8.00% Notes provides for customary events of default. As of June 30, 2017 , the Company was in compliance with respect to the terms of the 2013 8.00% Notes and the Indenture. Subject to certain conditions set forth in the Indenture, the Company may redeem the 2013 8.00% Notes, with the prior approval of the majority lenders under the Facility Agreement, in whole or in part, at any time on or after April 1, 2018, at a price equal to the principal amount of the 2013 8.00% Notes to be redeemed plus all accrued and unpaid interest thereon. A holder of the 2013 8.00% Notes has the right, at the holder’s option, to require the Company to purchase some or all of the 2013 8.00% Notes held by it on each of April 1, 2018 and April 1, 2023 at a price equal to the principal amount of the 2013 8.00% Notes to be purchased plus accrued and unpaid interest. Subject to the procedures for conversion and other terms and conditions of the Indenture, a holder may convert its 2013 8.00% Notes at its option at any time prior to the close of business on the business day immediately preceding April 1, 2028 , into shares of common stock (or, at the option of the Company, cash in lieu of all or a portion thereof, provided that, under the Facility Agreement, the Company may pay cash only with the consent of the Majority Lenders). As of June 30, 2017 , holders had converted a total of $39.4 million principal amount of the 2013 8.00% Notes, resulting in the issuance of approximately 72.1 million shares of voting common stock. There were no conversions during the three and six -month periods ending June 30, 2017 . Holders who convert 2013 8.00% Notes receive conversion shares over a 40 -consecutive trading day settlement period. Accordingly, the portion of converted debt is extinguished on an incremental basis over the 40 -day settlement period, reducing the Company's outstanding debt balance. As of June 30, 2017 , no conversions had been initiated but not yet fully settled. The Company evaluated the various embedded derivatives within the Indenture for the 2013 8.00% Notes. The Company determined that the conversion option and the contingent put feature within the Indenture required bifurcation from the 2013 8.00% Notes. The Company did not deem the conversion option and the contingent put feature to be clearly and closely related to the 2013 8.00% Notes and separately accounted for them as a standalone derivative. The Company recorded this compound embedded derivative liability as a non-current liability on its condensed consolidated balance sheets with a corresponding debt discount which is netted against the face value of the 2013 8.00% Notes. The Company is accreting the debt discount associated with the compound embedded derivative liability to interest expense through the first put date of the 2013 8.00% Notes (April 1, 2018) using an effective interest rate method. The Company is marking to market the fair value of the compound embedded derivative liability at the end of each reporting period, with any changes in value reported in the condensed consolidated statements of operations. The Company determines the fair value of the compound embedded derivative using a blend of a Monte Carlo simulation model and market prices. The amount by which the if-converted value of the 2013 8.00% Notes exceeded the principal amount at June 30, 2017 , assuming conversion at the closing price of the Company's common stock on that date of $2.13 per share, is approximately $33.1 million . Warrants Outstanding Pursuant to the terms of the Contingent Equity Agreement with Thermo (See Note 9: Related Party Transactions in the Consolidated Financial Statements in the 2016 Annual Report for a description of the Contingent Equity Agreement), the Company issued to Thermo 41.5 million warrants at a strike price of $0.01 to purchase shares of common stock pursuant to the annual availability fee and subsequent reset provisions in the Contingent Equity Agreement. These warrants were issued between June 2009 and June 2012 and have a five -year exercise period from issuance. In May 2017, Thermo exercised the remaining 24.6 million of the total 41.5 million warrants issued, resulting in the issuance of 24.6 million shares of the Company's common stock. As of June 30, 2017 , no warrants remain outstanding under this agreement. Terrapin Opportunity, L.P. Common Stock Purchase Agreement In August 2015, the Company entered into a common stock purchase agreement with Terrapin pursuant to which the Company could require Terrapin to purchase up to $75.0 million of shares of the Company’s voting common stock over the 24 -month term following the date of the agreement. Through the term of this agreement, Terrapin purchased a total of 67.3 million shares of voting common stock for a total purchase price of $75.0 million . In January 2017, the Company drew $12.0 million and issued to Terrapin 8.9 million shares of voting common stock. No funds remain available under this agreement.

Derivatives

Derivatives	6 Months Ended
	Jun. 30, 2017
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivatives	4. DERIVATIVES In connection with certain existing borrowing arrangements, the Company was required to record derivative instruments on its condensed consolidated balance sheets. None of these derivative instruments is designated as a hedge. The following table discloses the fair values of the derivative instruments on the Company’s condensed consolidated balance sheets (in thousands): June 30, 2017 December 31, 2016 Derivative assets: Interest rate cap $ 1 $ 4 Total derivative assets $ 1 $ 4 Derivative liabilities: Compound embedded derivative with the 2013 8.00% Notes $ (36,860 ) $ (26,664 ) Compound embedded derivative with the Thermo Loan Agreement (318,215 ) (254,507 ) Total derivative liabilities $ (355,075 ) $ (281,171 ) The following table discloses the changes in value recorded as derivative gain (loss) in the Company’s condensed consolidated statement of operations (in thousands): Three Months Ended Six Months Ended June 30, 2017 June 30, 2016 June 30, 2017 June 30, 2016 Interest rate cap $ (1 ) $ (1 ) $ (3 ) $ (5 ) Compound embedded derivative with the 2013 8.00% Notes (11,354 ) 5,335 (10,196 ) 5,783 Compound embedded derivative with the Thermo Loan Agreement (65,775 ) 35,165 (63,708 ) 33,377 Total derivative gain (loss) $ (77,130 ) $ 40,499 $ (73,907 ) $ 39,155 Intangible and Other Assets Interest Rate Cap In June 2009, in connection with entering into the Facility Agreement, under which interest accrues at a variable rate, the Company entered into five ten -year interest rate cap agreements. The interest rate cap agreements reflect a variable notional amount at interest rates that provide coverage to the Company for exposure resulting from escalating interest rates over the term of the Facility Agreement. The interest rate cap provides limits on the six-month Libor rate (“Base Rate”) used to calculate the coupon interest on outstanding amounts on the Facility Agreement and is capped at 5.50% should the Base Rate not exceed 6.5% . Should the Base Rate exceed 6.5% , the Company’s Base Rate will be 1% less than the then six-month Libor rate. The Company paid an approximately $12.4 million upfront fee for the interest rate cap agreements. The interest rate cap did not qualify for hedge accounting treatment, and changes in the fair value of the agreements are included in the condensed consolidated statements of operations. Derivative Liabilities The Company has identified various embedded derivatives resulting from certain features in the Company’s debt instruments, including the conversion option and the contingent put feature within both the 2013 8.00% Notes and the Thermo Loan Agreement. These embedded derivatives required bifurcation from the debt host agreement and are recorded as a derivative liability on the Company’s condensed consolidated balance sheets with a corresponding debt discount netted against the principal amount of the related debt instrument. The Company accretes the debt discount associated with each derivative liability to interest expense over the term of the related debt instrument using an effective interest rate method. The fair value of each embedded derivative liability is marked-to-market at the end of each reporting period with any changes in value reported in its condensed consolidated statements of operations. The Company determined the fair value of its compound embedded derivative liabilities using a blend of a Monte Carlo simulation model and market prices. See Note 5: Fair Value Measurements for further discussion. As the first put date for the 2013 8.00% Notes is on April 1, 2018, the Company has classified this derivative liability as current on its condensed consolidated balance sheet at June 30, 2017.

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jun. 30, 2017
Fair Value Disclosures [Abstract]
Fair Value Measurements	5. FAIR VALUE MEASUREMENTS The Company follows the authoritative guidance for fair value measurements relating to financial and non-financial assets and liabilities, including presentation of required disclosures herein. This guidance establishes a fair value framework requiring the categorization of assets and liabilities into three levels based upon the assumptions (inputs) used to price the assets and liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3 generally requires significant management judgment. The three levels are defined as follows: Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical assets or liabilities. Level 2: Quoted prices in markets that are not active or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability. Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity). Recurring Fair Value Measurements The following tables provide a summary of the financial assets and liabilities measured at fair value on a recurring basis (in thousands): June 30, 2017 (Level 1) (Level 2) (Level 3) Total Balance Assets: Interest rate cap $ — $ 1 $ — $ 1 Total assets measured at fair value $ — $ 1 $ — $ 1 Liabilities: Compound embedded derivative with 2013 8.00% Notes — — (36,860 ) (36,860 ) Compound embedded derivative with the Thermo Loan Agreement — — (318,215 ) (318,215 ) Total liabilities measured at fair value $ — $ — $ (355,075 ) $ (355,075 ) December 31, 2016 (Level 1) (Level 2) (Level 3) Total Balance Assets: Interest rate cap $ — $ 4 $ — $ 4 Total assets measured at fair value $ — $ 4 $ — $ 4 Liabilities: Liability for potential stock issuance to Hughes $ — $ (2,706 ) $ — $ (2,706 ) Liability for stock issuance due to legal settlement — (389 ) — (389 ) Compound embedded derivative with 2013 8.00% Notes — — (26,664 ) (26,664 ) Compound embedded derivative with the Thermo Loan Agreement — — (254,507 ) (254,507 ) Total liabilities measured at fair value $ — $ (3,095 ) $ (281,171 ) $ (284,266 ) Assets Interest Rate Cap The fair value of the interest rate cap is determined using observable pricing inputs including benchmark yields, reported trades, and broker/dealer quotes at the reporting date. See Note 4: Derivatives for further discussion. Liabilities Liability for potential stock issuance to Hughes As described in Note 6: Commitments and Contingencies , the Company agreed to provide downside protection after the issuance of shares of common stock to Hughes in lieu of cash for contract payments in June 2015. This feature required the Company to issue to Hughes additional shares of common stock equal to the difference, if any, between the initial consideration of $15.5 million and the total amount of gross proceeds Hughes received from the sale of any shares plus the market value of any shares still held by Hughes as of the close of trading on June 30, 2017. In April 2017, Hughes sold all remaining shares of Globalstar common stock and the Company was not required to issue additional shares. Prior to settlement, this liability was recorded on the Company's condensed consolidated balance sheet in accrued expenses and was marked-to-market at each balance sheet date. The value of this option was calculated using a Black-Scholes pricing model. The Company recorded gains and losses resulting from changes in the value of this liability in its condensed consolidated statement of operations. As of June 30, 2017, this liability was no longer outstanding. Liability for future stock issuance due to legal settlement As described in Note 6: Commitments and Contingencies , the Company settled litigation related to its Brazilian subsidiary in October 2016 through the payment of Globalstar common stock. In connection with this settlement, the Company agreed to provide downside protection for the difference between the total settlement amount and the total amount of gross proceeds the counterparty receives from the sale of these shares. An estimate of $0.4 million for this liability was recorded in accrued expenses in the Company's condensed consolidated financial statements as of December 31, 2016 . In March 2017, the Company settled this liability through the final payment of approximately 0.3 million shares of Globalstar common stock. Derivative Liabilities The Company has two derivative liabilities classified as Level 3. The Company marks-to-market these liabilities at each reporting date with the changes in fair value recognized in the Company’s condensed consolidated statements of operations. See Note 4: Derivatives for further discussion. The significant quantitative Level 3 inputs utilized in the valuation models are shown in the tables below: June 30, 2017 Stock Price Volatility Risk-Free Interest Rate Note Conversion Price Discount Rate Market Price of Common Stock Compound embedded derivative with the 2013 8.00% Notes 90% 1.2 % $ 0.73 26 % $ 2.13 Compound embedded derivative with the Thermo Loan Agreement 40% - 85% 2.0 % $ 0.73 26 % $ 2.13 December 31, 2016 Stock Price Volatility Risk-Free Interest Rate Note Conversion Price Discount Rate Market Price of Common Stock Compound embedded derivative with the 2013 8.00% Notes 100% - 110% 1.0 % $ 0.73 25 % $ 1.58 Compound embedded derivative with the Thermo Loan Agreement 40% - 110% 2.2 % $ 0.73 25 % $ 1.58 Fluctuation in the Company’s stock price is the primary driver for the changes in the derivative valuations during each reporting period. As the stock price increases away from the current conversion price for each of the related derivative instruments, the value to the holder of the instrument generally increases, thereby increasing the liability on the Company’s condensed consolidated balance sheets. These valuations are sensitive to the weighting applied to each of the simulated values. Additionally, stock price volatility is one of the significant unobservable inputs used in the fair value measurement of each of the Company’s derivative instruments. The simulated fair value of these liabilities is sensitive to changes in the expected volatility of the Company's stock price. Decreases in expected volatility would generally result in a lower fair value measurement. Probability of a change of control is another significant unobservable input used in the fair value measurement of the Company’s derivative instruments. Subject to certain restrictions in each indenture, the Company’s debt instruments contain certain provisions whereby holders may require the Company to purchase all or any portion of the convertible debt instrument upon a change of control. A change of control will occur upon certain changes in the ownership of the Company or certain events relating to the trading of the Company’s common stock. The simulated fair value of the derivative liabilities above is sensitive to changes in the assumed probabilities of a change of control. Decreases in the assumed probability of a change of control would generally result in a lower fair value measurement. In addition to the inputs described above, the valuation model used to calculate the fair value measurement of the compound embedded derivatives within the Company’s 2013 8.00% Notes and Thermo Loan Agreement included the following inputs and features: discount rate, payment in kind interest payments, make whole premiums, a 40 -day stock issuance settlement period upon conversion, automatic conversions, estimated maturity date, and the principal balance of each loan at the balance sheet date. There are also certain put and call features within the 2013 8.00% Notes that impact the valuation model. The trading activity in the market provides the Company with additional valuation support. The Company uses a weight factor to calculate the fair value of the embedded derivatives to align the fair value produced from the Monte Carlo simulation model with the market value of the 2013 8.00% Notes. Due to the similarities of the debt instruments, the Company applies a similar weight to the embedded derivative in the Thermo Loan Agreement. These valuations are sensitive to the weighting applied to each of the simulated values. The following table presents a rollforward for all liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) (in thousands): Three Months Ended June 30, Six months ended June 30, 2017 2016 2017 2016 Balance at beginning of period $ (277,946 ) $ (240,982 ) $ (281,171 ) $ (239,642 ) Unrealized gain (loss), included in derivative gain (loss) (77,129 ) 40,500 (73,904 ) 39,160 Balance at end of period $ (355,075 ) $ (200,482 ) $ (355,075 ) $ (200,482 ) Fair Value of Debt Instruments The Company believes it is not practicable to determine the fair value of the Facility Agreement without incurring significant additional costs. Unlike typical long-term debt, interest rates and other terms for the Facility Agreement are not readily available and generally involve a variety of factors, including due diligence by the debt holders. The following table sets forth the carrying values and estimated fair values of the Company's other debt instruments, which are classified as Level 3 financial instruments (in thousands): June 30, 2017 December 31, 2016 Carrying Value Estimated Fair Value Carrying Value Estimated Fair Value Thermo Loan Agreement $ 71,741 $ 51,045 $ 64,347 $ 47,874 2013 8.00% Notes 15,726 15,459 14,572 14,350

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2017
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	6. COMMITMENTS AND CONTINGENCIES Contractual Obligations - Next-Generation Gateways and Other Ground Facilities As of June 30, 2017 , the Company had purchase commitments with Thales, Hughes and Ericsson related to the procurement, deployment and maintenance of the second-generation network. The Company is obligated to make payments under these purchase commitments totaling approximately $1.1 million during 2017, all of which are owed to Ericsson and were accrued on its condensed consolidated balance sheet in accrued expenses as of June 30, 2017 . Hughes designed, supplied and implemented the Radio Access Network ("RAN") ground network equipment and software upgrades for installation at a number of the Company’s gateways. Hughes also provided the satellite interface chips to be used in various second-generation Globalstar devices. Ericsson developed, implemented and installed the Company's ground interface, or core network system, at certain of the Company's gateways. The second-generation Ericsson core links the Hughes RANs to the public-switched telephone network (“PSTN”), cellular networks and Internet. In December 2016, the Company formally accepted all contract deliverables under the core contracts for both Hughes and Ericsson necessary to deploy its second-generation ground infrastructure. The Company intends to complete certain add-ons outside of the scope of the core contracts, which include certain punch list items with Ericsson and the installation of second-generation RANs at certain additional gateways. In April 2015, Hughes exercised an option to be paid in shares of the Company's common stock (at a price 7% below market) in lieu of cash for certain of its remaining contract payments, totaling approximately $15.5 million . In June 2015, the Company issued 7.4 million shares of freely tradable common stock at the 7% discount pursuant to this option. In the April 2015 agreement (as amended), the Company agreed to provide downside protection through June 30, 2017. This feature required that the Company issue additional shares of common stock equal to the difference, if any, between the initial consideration of $15.5 million and the total amount of gross proceeds Hughes received from the sale of any shares plus the market value of any shares still held by Hughes as of the close of trading on June 30, 2017. In April 2017, Hughes sold all remaining shares of Globalstar common stock. The Company was not required to issue additional shares. See Note 5: Fair Value Measurements for further discussion of the fair value of this liability. Arbitration On June 3, 2011, Globalstar filed a demand for arbitration against Thales before the American Arbitration Association to enforce certain rights to order additional satellites under the 2009 Contract. The Company did not include within its demand any claims that it had against Thales for work previously performed under the contract to design, manufacture and timely deliver the first 25 second-generation satellites. On May 10, 2012, the arbitration tribunal issued its award in which it determined that the Company had terminated the 2009 Contract "for convenience" and had materially breached the contract by failing to pay to Thales the €51.3 million in termination charges required under the contract. The tribunal additionally determined that absent further agreement between the parties, Thales had no further obligation to manufacture or deliver satellites under Phase 3 of the 2009 Contract. Based on these determinations, the tribunal directed the Company to pay Thales approximately €53 million in termination charges, plus interest by June 9, 2012. On May 23, 2012, Thales commenced an action in the United States District Court for the Southern District of New York by filing a petition to confirm the arbitration award (the “New York Proceeding”). Thales and the Company entered into a tolling agreement as of June 13, 2013, under which Thales dismissed the New York Proceeding without prejudice. The tolling agreement has expired. Thales may refile the petition at a later date and pursue the confirmation of the arbitration award, which the Company would oppose. Should Thales be successful in confirming the arbitration award, this would have a material adverse effect on the Company's financial condition, results of operations and liquidity. On June 24, 2012, the Company and Thales agreed to settle their prior commercial disputes, including those disputes that were the subject of the arbitration award. In order to effectuate this settlement, the Company and Thales entered into a Release Agreement, a Settlement Agreement and a Submission Agreement. Under the terms of the Release Agreement, Thales agreed unconditionally and irrevocably to release and forever discharge the Company from any and all claims and obligations (with the exception of those items payable under the Settlement Agreement or in connection with a new contract for the purchase of any additional second-generation satellites), including, without limitation, a full release from paying €35.6 million of the termination charges awarded in the arbitration together with all interest on the award amount effective upon the earlier of December 31, 2012, and the effective date of the financing for the purchase of any additional second-generation satellites. Under the terms of the Release Agreement, the Company agreed unconditionally and irrevocably to release and forever discharge Thales from any and all claims (with limited exceptions), including, without limitation, claims related to Thales’ work under the 2009 satellite construction contract, including any obligation to pay liquidated damages, effective upon the earlier of December 31, 2012, and the effective date of the financing for the purchase of any additional second-generation satellites. In connection with the Release Agreement and the Settlement Agreement, the Company recorded a contract termination charge of approximately €17.5 million which is recorded in the Company’s condensed consolidated balance sheets as of June 30, 2017 and December 31, 2016 . The releases became effective on December 31, 2012. Under the terms of the Settlement Agreement, the Company agreed to pay €17.5 million to Thales, representing one-third of the termination charges awarded to Thales in the arbitration, subject to certain conditions, on the later of the effective date of the new contract for the purchase of any additional second-generation satellites and the effective date of the financing for the purchase of these satellites. As of June 30, 2017 , this condition had not been satisfied. Because the effective date of the new contract for the purchase of additional second-generation satellites did not occur on or prior to February 28, 2013, any party may terminate the Settlement Agreement. If any party terminates the Settlement Agreement, all parties’ rights and obligations under the Settlement Agreement shall terminate. The Release Agreement is a separate and independent agreement from the Settlement Agreement and provides that it supersedes all prior understandings, commitments and representations between the parties with respect to the subject matter thereof; therefore it would survive any termination of the Settlement Agreement. As of June 30, 2017 , no party had terminated the Settlement Agreement. Litigation Due to the nature of the Company's business, the Company is involved, from time to time, in various litigation matters or subject to disputes or routine claims regarding its business activities. Legal costs related to these matters are expensed as incurred. In 2016, the Company settled litigation incurred on behalf of the Company's Brazilian subsidiary. The Company paid the total settlement of 4.5 million reais, or $1.4 million , by issuing approximately 1.3 million shares of Globalstar common stock in October 2016. The Company agreed to provide downside protection for the difference between the total settlement amount of 4.5 million reais and the total gross proceeds received by the third party upon sale of these shares. In March 2017, the Company paid 0.3 million shares of Globalstar common stock related to this downside protection, valued at 1.4 million reais, or $0.5 million . In management's opinion, there is no pending litigation, dispute or claim, other than those described in this report, which could be expected to have a material adverse effect on the Company's financial condition, results of operations or liquidity.

Related Party Transactions

Related Party Transactions	6 Months Ended
	Jun. 30, 2017
Related Party Transactions [Abstract]
Related Party Transactions	7. RELATED PARTY TRANSACTIONS Payables to Thermo and other affiliates related to normal purchase transactions were $0.3 million as of June 30, 2017 and December 31, 2016 , respectively. Transactions with Thermo General and administrative expenses are related to non-cash expenses and those expenses incurred by Thermo on behalf of the Company which are charged to the Company. Non-cash expenses, which the Company accounts for as a contribution to capital, relate to services provided by two executive officers of Thermo (who are also directors of the Company) and receive no cash compensation from the Company. The Thermo expense charges are based on actual amounts (with no mark-up) incurred or upon allocated employee time. Those expenses charged to the Company were $0.2 million during the three months ended June 30, 2017 and 2016 and $0.4 million and $0.3 million for the six months ended June 30, 2017 and 2016 , respectively. As of June 30, 2017 , the principal amount outstanding under the Loan Agreement with Thermo was $99.8 million , and the fair value of the compound embedded derivative liability associated with the Loan Agreement was $318.2 million . During the three months ended June 30, 2017 and 2016 , interest accrued on the Loan Agreement was approximately $3.0 million and $2.6 million , respectively. During the six months ended June 30, 2017 and 2016 , interest accrued on the Loan Agreement was approximately and $5.8 million and $5.2 million , respectively. In May 2017, Thermo exercised all remaining warrants to purchase approximately 24.6 million shares issued under the Contingent Equity Agreement for a purchase price of $0.2 million . In June 2017, the Company and Thermo entered into a Common Stock Purchase Agreement in connection with the amendment and restatement of the Company's Facility Agreement. The Facility Agreement requires Thermo to maintain minimum and maximum ownership levels in the Company's common stock. Thermo may convert shares of nonvoting common stock into shares of voting common stock as needed to comply with these ownership limitations. In 2013, the Company's Board of Directors formed a special committee consisting solely of independent directors of the Company, represented by independent legal counsel. This special committee serves as an independent board to review and approve certain transactions between the Company and Thermo. See Note 3: Long-Term Debt and Other Financing Arrangements for further discussion of the Company's debt and financing transactions with Thermo.

Earnings (Loss) Per Share

Earnings (Loss) Per Share	6 Months Ended
	Jun. 30, 2017
Earnings Per Share [Abstract]
Earnings (Loss) Per Share	8. EARNINGS (LOSS) PER SHARE Basic earnings (loss) per share are computed based on the weighted average number of shares of common stock outstanding during the period. Common stock equivalents are included in the calculation of diluted earnings per share only when the effect of their inclusion would be dilutive. The following table sets forth the calculation of basic and diluted earnings (loss) per share for the periods indicated (in thousands): Three Months Ended Six Months Ended 2017 2016 2017 2016 Net income (loss) $ (98,734 ) $ 14,099 $ (118,895 ) $ (12,848 ) Effect of dilutive securities: 2013 8.00% Notes — 537 — — Thermo Loan Agreement — 2,401 — — Income (loss) to common stockholders plus assumed conversions $ (98,734 ) $ 17,037 $ (118,895 ) $ (12,848 ) Weighted average common shares outstanding: Basic shares outstanding 1,128,985 1,049,381 1,121,518 1,045,205 Incremental shares from assumed exercises, conversions and other issuances: Stock options, restricted stock, restricted stock units and ESPP — 5,793 — — 2013 8.00% Notes — 27,164 — — Thermo Loan Agreement — 139,709 — — Warrants and other — 27,625 — — Diluted shares outstanding 1,128,985 1,249,672 1,121,518 1,045,205 Net income (loss) per common share: Basic $ (0.09 ) $ 0.01 (0.11 ) (0.01 ) Diluted (0.09 ) 0.01 (0.11 ) (0.01 ) For the six months ended June 30, 2017 and 2016 , 191.6 million and 197.0 million shares, respectively, of potential common stock were excluded from diluted shares outstanding because the effects of assuming issuance of these potentially dilutive securities would be anti-dilutive. For the three months ended June 30, 2017 , the number of shares excluded from diluted shares outstanding was 190.5 million .

Condensed Consolidating Financi

Condensed Consolidating Financial Information	6 Months Ended
	Jun. 30, 2017
SUPPLEMENTAL CONSOLIDATING FINANCIAL INFORMATION [Abstract]
Condensed Consolidating Financial Information	9. CONDENSED CONSOLIDATING FINANCIAL INFORMATION In connection with the Company’s issuance of the 2013 8.00% Notes, certain of the Company’s 100% owned domestic subsidiaries (the “Guarantor Subsidiaries”), fully, unconditionally, jointly, and severally guaranteed the payment obligations under the 2013 8.00% Notes. The following financial information sets forth, on a consolidating basis, the balance sheets, statements of operations and statements of cash flows for Globalstar, Inc. (the “Parent Company”), for the Guarantor Subsidiaries and for the Parent Company’s other subsidiaries (the “Non-Guarantor Subsidiaries”). The condensed consolidating financial information has been prepared pursuant to the rules and regulations for condensed financial information and does not include disclosures included in annual financial statements. The principal eliminating entries eliminate investments in subsidiaries, intercompany balances and intercompany revenues and expenses. Globalstar, Inc. Condensed Consolidating Statement of Operations Three Months Ended June 30, 2017 (Unaudited) Parent Company Guarantor Subsidiaries Non- Guarantor Subsidiaries Eliminations Consolidated (In thousands) Revenue: Service revenues $ 18,685 $ 9,846 $ 13,096 $ (17,326 ) $ 24,301 Subscriber equipment sales 60 3,702 1,491 (1,431 ) 3,822 Total revenue 18,745 13,548 14,587 (18,757 ) 28,123 Operating expenses: Cost of services (exclusive of depreciation, amortization, and accretion shown separately below) 6,415 1,403 1,974 (756 ) 9,036 Cost of subscriber equipment sales 32 3,106 1,525 (1,885 ) 2,778 Marketing, general and administrative 5,312 997 19,357 (16,122 ) 9,544 Depreciation, amortization and accretion 19,101 120 54 — 19,275 Total operating expenses 30,860 5,626 22,910 (18,763 ) 40,633 Income (loss) from operations (12,115 ) 7,922 (8,323 ) 6 (12,510 ) Other income (expense): Gain on equity issuance 1,964 — — — 1,964 Interest income and expense, net of amounts capitalized (8,829 ) 7 (32 ) 4 (8,850 ) Derivative loss (77,130 ) — — — (77,130 ) Equity in subsidiary earnings (loss) (1,282 ) (4,076 ) — 5,358 — Other (1,342 ) (337 ) (418 ) (5 ) (2,102 ) Total other income (expense) (86,619 ) (4,406 ) (450 ) 5,357 (86,118 ) Income (loss) before income taxes (98,734 ) 3,516 (8,773 ) 5,363 (98,628 ) Income tax expense — 4 102 — 106 Net income (loss) $ (98,734 ) $ 3,512 $ (8,875 ) $ 5,363 $ (98,734 ) Comprehensive income (loss) $ (98,734 ) $ 3,512 $ (8,911 ) $ 5,354 $ (98,779 ) Globalstar, Inc. Condensed Consolidating Statement of Operations Three Months Ended June 30, 2016 (Unaudited) Parent Company Guarantor Subsidiaries Non- Guarantor Subsidiaries Eliminations Consolidated (In thousands) Revenue: Service revenues $ 10,944 $ 10,863 $ 10,689 $ (11,526 ) $ 20,970 Subscriber equipment sales 96 2,774 1,997 (751 ) 4,116 Total revenue 11,040 13,637 12,686 (12,277 ) 25,086 Operating expenses: Cost of services (exclusive of depreciation, amortization, and accretion shown separately below) 5,135 1,034 2,702 (934 ) 7,937 Cost of subscriber equipment sales 43 2,112 1,478 (747 ) 2,886 Marketing, general and administrative 5,430 1,322 16,219 (11,521 ) 11,450 Depreciation, amortization and accretion 18,851 206 288 (121 ) 19,224 Total operating expenses 29,459 4,674 20,687 (13,323 ) 41,497 Income (loss) from operations (18,419 ) 8,963 (8,001 ) 1,046 (16,411 ) Other income (expense): Loss on equity issuance (2,075 ) — — — (2,075 ) Interest income and expense, net of amounts capitalized (9,000 ) (3 ) (47 ) 1 (9,049 ) Derivative gain 40,499 — — — 40,499 Equity in subsidiary earnings (loss) 2,924 (968 ) — (1,956 ) — Other 170 92 328 95 685 Total other income (expense) 32,518 (879 ) 281 (1,860 ) 30,060 Income (loss) before income taxes 14,099 8,084 (7,720 ) (814 ) 13,649 Income tax benefit — — (450 ) — (450 ) Net income (loss) $ 14,099 $ 8,084 $ (7,270 ) $ (814 ) $ 14,099 Comprehensive income (loss) $ 14,099 $ 8,084 $ (8,195 ) $ (814 ) $ 13,174 Globalstar, Inc. Condensed Consolidating Statement of Operations Six Months Ended June 30, 2017 (Unaudited) Parent Guarantor Non- Eliminations Consolidated (In thousands) Revenue: Service revenues $ 36,297 $ 19,202 $ 24,097 $ (33,814 ) $ 45,782 Subscriber equipment sales 127 5,993 2,841 (1,968 ) 6,993 Total revenue 36,424 25,195 26,938 (35,782 ) 52,775 Operating expenses: Cost of services (exclusive of depreciation, amortization, and accretion shown separately below) 12,543 2,828 5,147 (2,508 ) 18,010 Cost of subscriber equipment sales 66 4,823 1,952 (1,967 ) 4,874 Marketing, general and administrative 10,971 2,116 37,265 (31,318 ) 19,034 Depreciation, amortization and accretion 38,052 402 115 — 38,569 Total operating expenses 61,632 10,169 44,479 (35,793 ) 80,487 Income (loss) from operations (25,208 ) 15,026 (17,541 ) 11 (27,712 ) Other income (expense): Gain (loss) on equity issuance 2,706 — (36 ) — 2,670 Interest income and expense, net of amounts capitalized (17,584 ) (1 ) (101 ) 8 (17,678 ) Derivative loss (73,907 ) — — — (73,907 ) Equity in subsidiary earnings (loss) (3,215 ) (7,510 ) — 10,725 — Other (1,687 ) (437 ) 5 (7 ) (2,126 ) Total other income (expense) (93,687 ) (7,948 ) (132 ) 10,726 (91,041 ) Income (loss) before income taxes (118,895 ) 7,078 (17,673 ) 10,737 (118,753 ) Income tax expense — 9 133 — 142 Net income (loss) $ (118,895 ) $ 7,069 $ (17,806 ) $ 10,737 $ (118,895 ) Comprehensive income (loss) $ (118,895 ) $ 7,069 $ (18,662 ) $ 10,728 $ (119,760 ) Globalstar, Inc. Condensed Consolidating Statement of Operations Six Months Ended June 30, 2016 (Unaudited) Parent Guarantor Non- Eliminations Consolidated (In thousands) Revenue: Service revenues $ 27,882 $ 18,358 $ 20,114 $ (26,635 ) $ 39,719 Subscriber equipment sales 424 4,466 3,674 (1,361 ) 7,203 Total revenue 28,306 22,824 23,788 (27,996 ) 46,922 Operating expenses: Cost of services (exclusive of depreciation, amortization, and accretion shown separately below) 9,948 2,070 5,597 (2,087 ) 15,528 Cost of subscriber equipment sales 187 3,540 2,693 (1,356 ) 5,064 Marketing, general and administrative 10,604 1,854 33,064 (25,462 ) 20,060 Depreciation, amortization and accretion 37,623 426 569 (239 ) 38,379 Total operating expenses 58,362 7,890 41,923 (29,144 ) 79,031 Income (loss) from operations (30,056 ) 14,934 (18,135 ) 1,148 (32,109 ) Other income (expense): Loss on equity issuance (1,923 ) — — — (1,923 ) Interest income and expense, net of amounts capitalized (17,981 ) (12 ) (152 ) (9 ) (18,154 ) Derivative gain 39,155 — — — 39,155 Equity in subsidiary earnings (loss) (1,427 ) 2,079 — (652 ) — Other (616 ) (112 ) 604 48 (76 ) Total other income (expense) 17,208 1,955 452 (613 ) 19,002 Income (loss) before income taxes (12,848 ) 16,889 (17,683 ) 535 (13,107 ) Income tax benefit — — (259 ) — (259 ) Net income (loss) $ (12,848 ) $ 16,889 $ (17,424 ) $ 535 $ (12,848 ) Comprehensive income (loss) $ (12,848 ) $ 16,889 $ (19,000 ) $ 535 $ (14,424 ) Globalstar, Inc. Condensed Consolidating Balance Sheet As of June 30, 2017 (Unaudited) Parent Company Guarantor Subsidiaries Non-Guarantor Subsidiaries Eliminations Consolidated (In thousands) ASSETS Current assets: Cash and cash equivalents $ 4,538 $ 1,975 $ 2,325 $ — $ 8,838 Accounts receivable 5,806 6,135 3,428 — 15,369 Intercompany receivables 938,139 717,066 46,098 (1,701,303 ) — Inventory 2,208 4,621 1,985 — 8,814 Prepaid expenses and other current assets 1,738 1,830 1,621 — 5,189 Total current assets 952,429 731,627 55,457 (1,701,303 ) 38,210 Property and equipment, net 1,005,671 3,751 4,371 5 1,013,798 Restricted cash 37,915 — — — 37,915 Intercompany notes receivable 7,447 — 6,436 (13,883 ) — Investment in subsidiaries (282,248 ) 78,753 37,502 165,993 — Intangible and other assets, net 17,321 87 2,650 (12 ) 20,046 Total assets $ 1,738,535 $ 814,218 $ 106,416 $ (1,549,200 ) $ 1,109,969 LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Current portion of long-term debt $ 108,720 $ — $ — $ — $ 108,720 Accounts payable 2,925 3,487 1,212 — 7,624 Accrued contract termination charge 20,026 — — — 20,026 Accrued expenses 7,713 6,097 6,854 — 20,664 Derivative Liabilities 36,860 — — — 36,860 Intercompany payables 673,426 773,216 254,622 (1,701,264 ) — Payables to affiliates 304 — — — 304 Deferred revenue 1,130 21,247 7,099 — 29,476 Total current liabilities 851,104 804,047 269,787 (1,701,264 ) 223,674 Long-term debt, less current portion 459,966 — — — 459,966 Employee benefit obligations 4,944 — — — 4,944 Intercompany notes payable 6,436 — 7,447 (13,883 ) — Derivative liabilities 318,215 — — — 318,215 Deferred revenue 5,468 384 14 — 5,866 Other non-current liabilities 928 325 4,577 — 5,830 Total non-current liabilities 795,957 709 12,038 (13,883 ) 794,821 Stockholders’ equity (deficit) 91,474 9,462 (175,409 ) 165,947 91,474 Total liabilities and stockholders’ equity $ 1,738,535 $ 814,218 $ 106,416 $ (1,549,200 ) $ 1,109,969 Globalstar, Inc. Condensed Consolidating Balance Sheet As of December 31, 2016 (Unaudited) Parent Company Guarantor Subsidiaries Non-Guarantor Subsidiaries Eliminations Consolidated (In thousands) ASSETS Current assets: Cash and cash equivalents $ 7,259 $ 1,327 $ 1,644 $ — $ 10,230 Accounts receivable 5,938 6,340 2,941 — 15,219 Intercompany receivables 897,691 678,707 32,040 (1,608,438 ) — Inventory 2,266 4,354 1,473 — 8,093 Prepaid expenses and other current assets 1,570 955 2,063 — 4,588 Total current assets 914,724 691,683 40,161 (1,608,438 ) 38,130 Property and equipment, net 1,031,623 3,708 4,384 4 1,039,719 Restricted cash 37,983 — — — 37,983 Intercompany notes receivable 8,901 — 6,436 (15,337 ) — Investment in subsidiaries (280,557 ) 73,029 36,146 171,382 — Intangible and other assets, net 15,259 128 1,407 (12 ) 16,782 Total assets $ 1,727,933 $ 768,548 $ 88,534 $ (1,452,401 ) $ 1,132,614 LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Current portion of long-term debt $ 75,755 $ — $ — $ — $ 75,755 Debt restructuring fees 20,795 — — — 20,795 Accounts payable 2,624 3,490 1,385 — 7,499 Accrued contract termination charge 18,451 — — — 18,451 Accrued expenses 10,573 5,884 6,705 — 23,162 Intercompany payables 636,336 750,084 221,980 (1,608,400 ) — Payables to affiliates 309 — — — 309 Deferred revenue 1,576 19,304 5,599 — 26,479 Total current liabilities 766,419 778,762 235,669 (1,608,400 ) 172,450 Long-term debt, less current portion 500,524 — — — 500,524 Employee benefit obligations 4,883 — — — 4,883 Intercompany notes payable 6,435 — 8,901 (15,336 ) — Derivative liabilities 281,171 — — — 281,171 Deferred revenue 5,567 299 11 — 5,877 Other non-current liabilities 1,115 325 4,450 — 5,890 Total non-current liabilities 799,695 624 13,362 (15,336 ) 798,345 Stockholders’ equity (deficit) 161,819 (10,838 ) (160,497 ) 171,335 161,819 Total liabilities and stockholders’ equity $ 1,727,933 $ 768,548 $ 88,534 $ (1,452,401 ) $ 1,132,614 Globalstar, Inc. Condensed Consolidating Statement of Cash Flows Six Months Ended June 30, 2017 (Unaudited) Parent Company Guarantor Subsidiaries Non- Guarantor Subsidiaries Eliminations Consolidated (In thousands) Cash flows provided by operating activities $ 4,008 $ 1,068 $ 1,180 $ — $ 6,256 Cash flows used in investing activities: Second-generation network costs (including interest) (6,498 ) — (32 ) — (6,530 ) Property and equipment additions (1,637 ) (420 ) (59 ) — (2,116 ) Purchase of intangible assets (1,552 ) — (492 ) — (2,044 ) Net cash used in investing activities (9,687 ) (420 ) (583 ) — (10,690 ) Cash flows provided by (used in) financing activities: Principal payments of the Facility Agreement (21,695 ) — — — (21,695 ) Proceeds from Thermo Common Stock Purchase Agreement 33,000 — — — 33,000 Payment of debt restructuring fee (20,795 ) — — — (20,795 ) Payment of debt amendment fee (255 ) — — — (255 ) Proceeds from issuance of stock to Terrapin 12,000 — — — 12,000 Proceeds from issuance of common stock and exercise of options and warrants 635 — — — 635 Net cash provided by financing activities 2,890 — — — 2,890 Effect of exchange rate changes on cash — — 84 — 84 Net increase (decrease) in cash, cash equivalents and restricted cash (2,789 ) 648 681 — (1,460 ) Cash, cash equivalents and restricted cash, beginning of period 45,242 1,327 1,644 — 48,213 Cash, cash equivalents and restricted cash, end of period $ 42,453 $ 1,975 $ 2,325 $ — $ 46,753 Globalstar, Inc. Condensed Consolidating Statement of Cash Flows Six Months Ended June 30, 2016 (Unaudited) Parent Company Guarantor Subsidiaries Non- Guarantor Subsidiaries Eliminations Consolidated (In thousands) Cash flows provided by (used in) operating activities $ 916 $ 255 $ (170 ) $ — $ 1,001 Cash flows used in investing activities: Second-generation network costs (including interest) (5,161 ) — (146 ) — (5,307 ) Property and equipment additions (5,937 ) (167 ) (241 ) — (6,345 ) Purchase of intangible assets (806 ) — — — (806 ) Net cash used in investing activities (11,904 ) (167 ) (387 ) — (12,458 ) Cash flows provided by (used in) financing activities: Principal payments of the Facility Agreement (16,418 ) — — — (16,418 ) Proceeds from issuance of stock to Terrapin 28,500 — — — 28,500 Proceeds from issuance of common stock and exercise of options and warrants 3,016 — — — 3,016 Net cash provided by financing activities 15,098 — — — 15,098 Effect of exchange rate changes on cash — — 152 — 152 Net increase (decrease) in cash, cash equivalents and restricted cash 4,110 88 (405 ) — 3,793 Cash, cash equivalents and restricted cash, beginning of period 41,448 719 3,227 — 45,394 Cash, cash equivalents and restricted cash, end of period $ 45,558 $ 807 $ 2,822 $ — $ 49,187

Basis of Presentation (Policies

Basis of Presentation (Policies)	6 Months Ended
	Jun. 30, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	1. BASIS OF PRESENTATION Globalstar, Inc. (“Globalstar” or the “Company”) provides Mobile Satellite Services (“MSS”) including voice and data communications services through its global satellite network. Thermo Capital Partners LLC, through its affiliates (collectively, “Thermo”), is the principal owner and largest stockholder of Globalstar. The Company’s Chairman and Chief Executive Officer controls Thermo. Two other members of the Company's Board of Directors are also directors, officers or minority equity owners of various Thermo entities. The Company has prepared the accompanying unaudited interim condensed consolidated financial statements in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) for interim financial information. Certain information and footnote disclosures normally in financial statements have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission (the "SEC"); however, management believes the disclosures made are adequate to make the information presented not misleading. These financial statements and notes should be read in conjunction with the consolidated financial statements and notes thereto included in the Globalstar Annual Report on Form 10-K for the year ended December 31, 2016 , as filed with the SEC on February 23, 2017 (the "2016 Annual Report"), and Management's Discussion and Analysis of Financial Condition and Results of Operations herein. The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from estimates. The Company evaluates estimates on an ongoing basis. Significant estimates include the value of derivative instruments, the allowance for doubtful accounts, the net realizable value of inventory, the useful life and value of property and equipment, the value of stock-based compensation and income taxes. The Company has made certain reclassifications to prior period condensed consolidated financial statements to conform to current period presentation. These unaudited interim condensed consolidated financial statements include the accounts of Globalstar and all its subsidiaries. All significant intercompany transactions and balances have been eliminated in the consolidation. In the opinion of management, the information included herein includes all adjustments, consisting of normal recurring adjustments, that are necessary for a fair presentation of the Company’s condensed consolidated statements of operations, condensed consolidated balance sheets, and condensed consolidated statements of cash flows for the periods presented. The results of operations for the three and six months ended June 30, 2017 are not necessarily indicative of the results that may be expected for the full year or any future period.
Recently Issued and Adopted Accounting Pronouncements	Recently Issued Accounting Pronouncements In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Updates ("ASU") No. 2014-09, Revenue from Contracts with Customers . ASU 2014-09 has been modified multiple times since its initial release. This ASU outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. ASU 2014-09, as amended, becomes effective for annual reporting periods beginning after December 15, 2017. Early adoption is permitted; however, the Company plans on adopting this standard when it becomes effective on January 1, 2018. The Company has an internal project team that is evaluating the impact this standard will have on its financial statements, accounting systems and related disclosures. Currently, the Company expects that the most significant changes to the Company's revenue recognition accounting policies will be related to the following: 1) the allocation and timing of revenue recognized between service revenue and subscriber equipment sales, 2) the timing of service revenue recognized for breakage during certain customer's prepaid contracts and 3) the deferment of certain contract acquisition costs and the recognition of these costs over the expected life of a customer's contract. The standard permits the use of either the retrospective or cumulative effect transition method. The Company expects to follow the cumulative effect method of adoption. In March 2016, the FASB issued ASU No. 2016-02, Leases . The main difference between the provisions of ASU No. 2016-02 and previous U.S. GAAP is the recognition of right-of-use assets and lease liabilities by lessees for those leases classified as operating leases under previous U.S. GAAP. ASU No. 2016-02 retains a distinction between finance leases and operating leases, and the recognition, measurement, and presentation of expenses and cash flows arising from a lease by a lessee have not significantly changed from previous U.S. GAAP. For leases with a term of 12 months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize right-of-use assets and lease liabilities. The accounting applied by a lessor is largely unchanged from that applied under previous U.S. GAAP. In transition, lessees and lessors are required to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach. This ASU is effective for public business entities in fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. Early adoption is permitted as of the beginning of any interim or annual reporting period. The Company is currently evaluating the impact this standard will have on its financial statements and related disclosures. In June 2016, the FASB issued ASU No. 2016-13, Credit Losses, Measurement of Credit Losses on Financial Instruments . ASU No. 2016-13 significantly changes how entities will measure credit losses for most financial assets and certain other instruments that are not measured at fair value through net income. The standard will replace today’s incurred loss approach with an expected loss model for instruments measured at amortized cost. Entities will apply the standard’s provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. This ASU is effective for public entities for annual and interim periods beginning after December 15, 2019. Early adoption is permitted for all entities for annual periods beginning after December 15, 2018, and interim periods therein. The Company has not yet determined the impact this standard will have on its financial statements and related disclosures. In January 2017, the FASB issued ASU No. 2017-01, Business Combinations: Clarifying the Definition of a Business . ASU 2017-01 most significantly revises guidance specific to the definition of a business related to accounting for acquisitions. Additionally, ASU 2017-01 also affects other areas of US GAAP, such as the definition of a business related to the consolidation of variable interest entities, the consolidation of a subsidiary or group of assets, components of an operating segment, and disposals of reporting units and the impact on goodwill. This ASU is effective for public entities for annual and interim periods beginning after December 15, 2017. Early adoption is permitted as of the beginning of any interim or annual reporting period. The Company does not expect it to have a material effect on the Company's condensed consolidated financial statements and related disclosures. In February 2017, the FASB issued ASU 2017-05, Other Income—Gains and Losses from the Derecognition of Nonfinancial Assets: Clarifying the Scope of Asset Derecognition Guidance and Accounting for Partial Sales of Nonfinancial Assets . ASU 2017-06 was issued to provide clarity on the scope and application for recognizing gains and losses from the sale or transfer of nonfinancial assets, and should be adopted concurrently with ASU 2014-09: Revenue from Contracts with Customers . This ASU is effective for public entities for annual and interim periods beginning after December 15, 2017. Early adoption is permitted as of the beginning of any interim or annual reporting period. The Company is currently evaluating the impact this standard will have on its financial statements and related disclosures. In February 2017, the FASB issued ASU 2017-07: Compensation—Retirement Benefits: Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost . ASU 2017-07 requires sponsors of benefit plans to present the service cost component of net periodic benefit cost in the same income statement line or items as other employee costs and present the remaining components of net periodic benefit cost in one or more separate line items outside of income from operations. This ASU also limits the capitalization of benefit costs to only the service cost component. This ASU is effective for public entities for annual and interim periods beginning after December 15, 2017. Early adoption is permitted as of the beginning of any interim or annual reporting period. The Company does not expect it to have a material effect on the Company's condensed consolidated financial statements and related disclosures. In March 2017, the FASB issued ASU 2017-08: Receivables—Nonrefundable Fees and Other Costs: Premium Amortization on Purchased Callable Debt Securities . This ASU amends current US GAAP to shorten the amortization period for certain purchased callable debt securities held at a premium to the earliest call date. This ASU is effective for public entities for annual and interim periods beginning after December 15, 2018. Early adoption is permitted as of the beginning of any interim or annual reporting period. The Company does not expect it to have a material effect on the Company's condensed consolidated financial statements and related disclosures. In May 2017, the FASB issued ASU 2017-09: Compensation—Stock Compensation: Scope of Modification Accounting. This ASU clarifies when changes to the terms or conditions of a share-based payment award must be accounted for as modifications. Under the new guidance, a company will apply modification accounting only if the fair value, vesting conditions or classification of the award change due to a modification in the terms or conditions of the share-based payment award. This ASU is effective for public entities for annual and interim periods beginning after December 15, 2017. Early adoption is permitted as of the beginning of any interim or annual reporting period. The Company does not expect it to have a material effect on the Company's condensed consolidated financial statements and related disclosures. In July 2017, the FASB issued ASU 2017-11: I. Accounting for Certain Financial Instruments With Down Round Features and II. Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests With a Scope Exception. Part I of this ASU reduces the complexity associated with accounting for certain financial instruments with down round features. Part II of this ASU recharacterizes the indefinite deferral provisions described in Topic 480: Distinguishing Liabilities from Equity. It does not have an accounting effect. This ASU is effective for public entities for annual and interim periods beginning after December 15, 2018. Early adoption is permitted as of the beginning of any interim or annual reporting period. The Company is currently evaluating the impact this standard will have on its financial statements and related disclosures. Recently Adopted Accounting Pronouncements In November 2016, the FASB issued ASU No. 2016-18, Statement of Cash Flows - Restricted Cash . ASU 2016-18 requires entities to show the changes in the total of cash, cash equivalents, restricted cash and restricted cash equivalents in the statement of cash flows. When cash, cash equivalents, restricted cash and restricted cash equivalents are presented in more than one line item on the balance sheet, a reconciliation of the totals in the statement of cash flows to the related captions in the balance sheet is required. This ASU is effective for public entities for annual and interim periods beginning after December 15, 2017. Early adoption is permitted as of the beginning of any interim or annual reporting period. The Company adopted this standard effective with reporting periods beginning on January 1, 2017 and reflected the impact of this standard using a retrospective transition method for each period presented. Additionally, the Company added required disclosures pursuant to ASC 2016-18 to its condensed consolidated statements of cash flows.
Derivatives, Embedded Derivatives	The Company has identified various embedded derivatives resulting from certain features in the Company’s debt instruments, including the conversion option and the contingent put feature within both the 2013 8.00% Notes and the Thermo Loan Agreement. These embedded derivatives required bifurcation from the debt host agreement and are recorded as a derivative liability on the Company’s condensed consolidated balance sheets with a corresponding debt discount netted against the principal amount of the related debt instrument. The Company accretes the debt discount associated with each derivative liability to interest expense over the term of the related debt instrument using an effective interest rate method. The fair value of each embedded derivative liability is marked-to-market at the end of each reporting period with any changes in value reported in its condensed consolidated statements of operations. The Company determined the fair value of its compound embedded derivative liabilities using a blend of a Monte Carlo simulation model and market prices. See Note 5: Fair Value Measurements for further discussion.
Fair Value Measurement	The Company follows the authoritative guidance for fair value measurements relating to financial and non-financial assets and liabilities, including presentation of required disclosures herein. This guidance establishes a fair value framework requiring the categorization of assets and liabilities into three levels based upon the assumptions (inputs) used to price the assets and liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3 generally requires significant management judgment. The three levels are defined as follows: Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical assets or liabilities. Level 2: Quoted prices in markets that are not active or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability. Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity).
Earnings Per Share	Basic earnings (loss) per share are computed based on the weighted average number of shares of common stock outstanding during the period. Common stock equivalents are included in the calculation of diluted earnings per share only when the effect of their inclusion would be dilutive.

Property and Equipment (Tables)

Property and Equipment (Tables)	6 Months Ended
	Jun. 30, 2017
Property, Plant and Equipment [Abstract]
Property and Equipment	Property and equipment consists of the following (in thousands): June 30, December 31, Globalstar System: Space component First and second-generation satellites in service $ 1,195,180 $ 1,211,090 Prepaid long-lead items 17,040 17,040 Second-generation satellite, on-ground spare 32,481 32,481 Ground component 48,562 48,400 Construction in progress: Space component 463 81 Ground component 217,199 207,127 Next-generation software upgrades 11,091 10,223 Other 1,917 2,299 Total Globalstar System 1,523,933 1,528,741 Internally developed and purchased software 16,530 15,005 Equipment 10,153 9,875 Land and buildings 3,319 3,330 Leasehold improvements 1,940 1,893 Total property and equipment 1,555,875 1,558,844 Accumulated depreciation (542,077 ) (519,125 ) Total property and equipment, net $ 1,013,798 $ 1,039,719

Long-Term Debt and Other Fina17

Long-Term Debt and Other Financing Arrangements (Tables)	6 Months Ended
	Jun. 30, 2017
Debt Disclosure [Abstract]
Schedule of long-term debt	Long-term debt consists of the following (in thousands): June 30, 2017 December 31, 2016 Principal Amount Unamortized Discount and Deferred Financing Costs Carrying Value Principal Amount Unamortized Discount and Deferred Financing Costs Carrying Value Facility Agreement $ 521,317 $ 40,098 $ 481,219 $ 543,011 $ 45,651 $ 497,360 Thermo Loan Agreement 99,776 28,035 71,741 93,962 29,615 64,347 8.00% Convertible Senior Notes Issued in 2013 17,319 1,593 15,726 17,126 2,554 14,572 Total Debt 638,412 69,726 568,686 654,099 77,820 576,279 Less: Current Portion 110,313 1,593 108,720 75,755 — 75,755 Long-Term Debt $ 528,099 $ 68,133 $ 459,966 $ 578,344 $ 77,820 $ 500,524

Derivatives (Tables)

Derivatives (Tables)	6 Months Ended
	Jun. 30, 2017
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of fair values of derivative instruments	The following table discloses the fair values of the derivative instruments on the Company’s condensed consolidated balance sheets (in thousands): June 30, 2017 December 31, 2016 Derivative assets: Interest rate cap $ 1 $ 4 Total derivative assets $ 1 $ 4 Derivative liabilities: Compound embedded derivative with the 2013 8.00% Notes $ (36,860 ) $ (26,664 ) Compound embedded derivative with the Thermo Loan Agreement (318,215 ) (254,507 ) Total derivative liabilities $ (355,075 ) $ (281,171 )
Schedule of derivative gains (losses)	The following table discloses the changes in value recorded as derivative gain (loss) in the Company’s condensed consolidated statement of operations (in thousands): Three Months Ended Six Months Ended June 30, 2017 June 30, 2016 June 30, 2017 June 30, 2016 Interest rate cap $ (1 ) $ (1 ) $ (3 ) $ (5 ) Compound embedded derivative with the 2013 8.00% Notes (11,354 ) 5,335 (10,196 ) 5,783 Compound embedded derivative with the Thermo Loan Agreement (65,775 ) 35,165 (63,708 ) 33,377 Total derivative gain (loss) $ (77,130 ) $ 40,499 $ (73,907 ) $ 39,155

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Jun. 30, 2017
Fair Value Disclosures [Abstract]
Financial assets and liabilities measured at fair value on recurring basis	The following tables provide a summary of the financial assets and liabilities measured at fair value on a recurring basis (in thousands): June 30, 2017 (Level 1) (Level 2) (Level 3) Total Balance Assets: Interest rate cap $ — $ 1 $ — $ 1 Total assets measured at fair value $ — $ 1 $ — $ 1 Liabilities: Compound embedded derivative with 2013 8.00% Notes — — (36,860 ) (36,860 ) Compound embedded derivative with the Thermo Loan Agreement — — (318,215 ) (318,215 ) Total liabilities measured at fair value $ — $ — $ (355,075 ) $ (355,075 ) December 31, 2016 (Level 1) (Level 2) (Level 3) Total Balance Assets: Interest rate cap $ — $ 4 $ — $ 4 Total assets measured at fair value $ — $ 4 $ — $ 4 Liabilities: Liability for potential stock issuance to Hughes $ — $ (2,706 ) $ — $ (2,706 ) Liability for stock issuance due to legal settlement — (389 ) — (389 ) Compound embedded derivative with 2013 8.00% Notes — — (26,664 ) (26,664 ) Compound embedded derivative with the Thermo Loan Agreement — — (254,507 ) (254,507 ) Total liabilities measured at fair value $ — $ (3,095 ) $ (281,171 ) $ (284,266 )
Schedule of significant quantitative level 3 inputs utilized	The significant quantitative Level 3 inputs utilized in the valuation models are shown in the tables below: June 30, 2017 Stock Price Volatility Risk-Free Interest Rate Note Conversion Price Discount Rate Market Price of Common Stock Compound embedded derivative with the 2013 8.00% Notes 90% 1.2 % $ 0.73 26 % $ 2.13 Compound embedded derivative with the Thermo Loan Agreement 40% - 85% 2.0 % $ 0.73 26 % $ 2.13 December 31, 2016 Stock Price Volatility Risk-Free Interest Rate Note Conversion Price Discount Rate Market Price of Common Stock Compound embedded derivative with the 2013 8.00% Notes 100% - 110% 1.0 % $ 0.73 25 % $ 1.58 Compound embedded derivative with the Thermo Loan Agreement 40% - 110% 2.2 % $ 0.73 25 % $ 1.58
Rollforward of liabilities measured at fair value	The following table presents a rollforward for all liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) (in thousands): Three Months Ended June 30, Six months ended June 30, 2017 2016 2017 2016 Balance at beginning of period $ (277,946 ) $ (240,982 ) $ (281,171 ) $ (239,642 ) Unrealized gain (loss), included in derivative gain (loss) (77,129 ) 40,500 (73,904 ) 39,160 Balance at end of period $ (355,075 ) $ (200,482 ) $ (355,075 ) $ (200,482 )
Schedule of carrying values and estimated fair values of debt instruments	The following table sets forth the carrying values and estimated fair values of the Company's other debt instruments, which are classified as Level 3 financial instruments (in thousands): June 30, 2017 December 31, 2016 Carrying Value Estimated Fair Value Carrying Value Estimated Fair Value Thermo Loan Agreement $ 71,741 $ 51,045 $ 64,347 $ 47,874 2013 8.00% Notes 15,726 15,459 14,572 14,350

Earnings (Loss) Per Share (Tabl

Earnings (Loss) Per Share (Tables)	6 Months Ended
	Jun. 30, 2017
Earnings Per Share [Abstract]
Reconciliation of basic weighted average share to diluted weighted average common shares outstanding	The following table sets forth the calculation of basic and diluted earnings (loss) per share for the periods indicated (in thousands): Three Months Ended Six Months Ended 2017 2016 2017 2016 Net income (loss) $ (98,734 ) $ 14,099 $ (118,895 ) $ (12,848 ) Effect of dilutive securities: 2013 8.00% Notes — 537 — — Thermo Loan Agreement — 2,401 — — Income (loss) to common stockholders plus assumed conversions $ (98,734 ) $ 17,037 $ (118,895 ) $ (12,848 ) Weighted average common shares outstanding: Basic shares outstanding 1,128,985 1,049,381 1,121,518 1,045,205 Incremental shares from assumed exercises, conversions and other issuances: Stock options, restricted stock, restricted stock units and ESPP — 5,793 — — 2013 8.00% Notes — 27,164 — — Thermo Loan Agreement — 139,709 — — Warrants and other — 27,625 — — Diluted shares outstanding 1,128,985 1,249,672 1,121,518 1,045,205 Net income (loss) per common share: Basic $ (0.09 ) $ 0.01 (0.11 ) (0.01 ) Diluted (0.09 ) 0.01 (0.11 ) (0.01 )

Condensed Consolidating Finan21

Condensed Consolidating Financial Information (Tables)	6 Months Ended
	Jun. 30, 2017
SUPPLEMENTAL CONSOLIDATING FINANCIAL INFORMATION [Abstract]
Supplemental condensed consolidating statement of operations	Globalstar, Inc. Condensed Consolidating Statement of Operations Three Months Ended June 30, 2017 (Unaudited) Parent Company Guarantor Subsidiaries Non- Guarantor Subsidiaries Eliminations Consolidated (In thousands) Revenue: Service revenues $ 18,685 $ 9,846 $ 13,096 $ (17,326 ) $ 24,301 Subscriber equipment sales 60 3,702 1,491 (1,431 ) 3,822 Total revenue 18,745 13,548 14,587 (18,757 ) 28,123 Operating expenses: Cost of services (exclusive of depreciation, amortization, and accretion shown separately below) 6,415 1,403 1,974 (756 ) 9,036 Cost of subscriber equipment sales 32 3,106 1,525 (1,885 ) 2,778 Marketing, general and administrative 5,312 997 19,357 (16,122 ) 9,544 Depreciation, amortization and accretion 19,101 120 54 — 19,275 Total operating expenses 30,860 5,626 22,910 (18,763 ) 40,633 Income (loss) from operations (12,115 ) 7,922 (8,323 ) 6 (12,510 ) Other income (expense): Gain on equity issuance 1,964 — — — 1,964 Interest income and expense, net of amounts capitalized (8,829 ) 7 (32 ) 4 (8,850 ) Derivative loss (77,130 ) — — — (77,130 ) Equity in subsidiary earnings (loss) (1,282 ) (4,076 ) — 5,358 — Other (1,342 ) (337 ) (418 ) (5 ) (2,102 ) Total other income (expense) (86,619 ) (4,406 ) (450 ) 5,357 (86,118 ) Income (loss) before income taxes (98,734 ) 3,516 (8,773 ) 5,363 (98,628 ) Income tax expense — 4 102 — 106 Net income (loss) $ (98,734 ) $ 3,512 $ (8,875 ) $ 5,363 $ (98,734 ) Comprehensive income (loss) $ (98,734 ) $ 3,512 $ (8,911 ) $ 5,354 $ (98,779 ) Globalstar, Inc. Condensed Consolidating Statement of Operations Three Months Ended June 30, 2016 (Unaudited) Parent Company Guarantor Subsidiaries Non- Guarantor Subsidiaries Eliminations Consolidated (In thousands) Revenue: Service revenues $ 10,944 $ 10,863 $ 10,689 $ (11,526 ) $ 20,970 Subscriber equipment sales 96 2,774 1,997 (751 ) 4,116 Total revenue 11,040 13,637 12,686 (12,277 ) 25,086 Operating expenses: Cost of services (exclusive of depreciation, amortization, and accretion shown separately below) 5,135 1,034 2,702 (934 ) 7,937 Cost of subscriber equipment sales 43 2,112 1,478 (747 ) 2,886 Marketing, general and administrative 5,430 1,322 16,219 (11,521 ) 11,450 Depreciation, amortization and accretion 18,851 206 288 (121 ) 19,224 Total operating expenses 29,459 4,674 20,687 (13,323 ) 41,497 Income (loss) from operations (18,419 ) 8,963 (8,001 ) 1,046 (16,411 ) Other income (expense): Loss on equity issuance (2,075 ) — — — (2,075 ) Interest income and expense, net of amounts capitalized (9,000 ) (3 ) (47 ) 1 (9,049 ) Derivative gain 40,499 — — — 40,499 Equity in subsidiary earnings (loss) 2,924 (968 ) — (1,956 ) — Other 170 92 328 95 685 Total other income (expense) 32,518 (879 ) 281 (1,860 ) 30,060 Income (loss) before income taxes 14,099 8,084 (7,720 ) (814 ) 13,649 Income tax benefit — — (450 ) — (450 ) Net income (loss) $ 14,099 $ 8,084 $ (7,270 ) $ (814 ) $ 14,099 Comprehensive income (loss) $ 14,099 $ 8,084 $ (8,195 ) $ (814 ) $ 13,174 Globalstar, Inc. Condensed Consolidating Statement of Operations Six Months Ended June 30, 2017 (Unaudited) Parent Guarantor Non- Eliminations Consolidated (In thousands) Revenue: Service revenues $ 36,297 $ 19,202 $ 24,097 $ (33,814 ) $ 45,782 Subscriber equipment sales 127 5,993 2,841 (1,968 ) 6,993 Total revenue 36,424 25,195 26,938 (35,782 ) 52,775 Operating expenses: Cost of services (exclusive of depreciation, amortization, and accretion shown separately below) 12,543 2,828 5,147 (2,508 ) 18,010 Cost of subscriber equipment sales 66 4,823 1,952 (1,967 ) 4,874 Marketing, general and administrative 10,971 2,116 37,265 (31,318 ) 19,034 Depreciation, amortization and accretion 38,052 402 115 — 38,569 Total operating expenses 61,632 10,169 44,479 (35,793 ) 80,487 Income (loss) from operations (25,208 ) 15,026 (17,541 ) 11 (27,712 ) Other income (expense): Gain (loss) on equity issuance 2,706 — (36 ) — 2,670 Interest income and expense, net of amounts capitalized (17,584 ) (1 ) (101 ) 8 (17,678 ) Derivative loss (73,907 ) — — — (73,907 ) Equity in subsidiary earnings (loss) (3,215 ) (7,510 ) — 10,725 — Other (1,687 ) (437 ) 5 (7 ) (2,126 ) Total other income (expense) (93,687 ) (7,948 ) (132 ) 10,726 (91,041 ) Income (loss) before income taxes (118,895 ) 7,078 (17,673 ) 10,737 (118,753 ) Income tax expense — 9 133 — 142 Net income (loss) $ (118,895 ) $ 7,069 $ (17,806 ) $ 10,737 $ (118,895 ) Comprehensive income (loss) $ (118,895 ) $ 7,069 $ (18,662 ) $ 10,728 $ (119,760 ) Globalstar, Inc. Condensed Consolidating Statement of Operations Six Months Ended June 30, 2016 (Unaudited) Parent Guarantor Non- Eliminations Consolidated (In thousands) Revenue: Service revenues $ 27,882 $ 18,358 $ 20,114 $ (26,635 ) $ 39,719 Subscriber equipment sales 424 4,466 3,674 (1,361 ) 7,203 Total revenue 28,306 22,824 23,788 (27,996 ) 46,922 Operating expenses: Cost of services (exclusive of depreciation, amortization, and accretion shown separately below) 9,948 2,070 5,597 (2,087 ) 15,528 Cost of subscriber equipment sales 187 3,540 2,693 (1,356 ) 5,064 Marketing, general and administrative 10,604 1,854 33,064 (25,462 ) 20,060 Depreciation, amortization and accretion 37,623 426 569 (239 ) 38,379 Total operating expenses 58,362 7,890 41,923 (29,144 ) 79,031 Income (loss) from operations (30,056 ) 14,934 (18,135 ) 1,148 (32,109 ) Other income (expense): Loss on equity issuance (1,923 ) — — — (1,923 ) Interest income and expense, net of amounts capitalized (17,981 ) (12 ) (152 ) (9 ) (18,154 ) Derivative gain 39,155 — — — 39,155 Equity in subsidiary earnings (loss) (1,427 ) 2,079 — (652 ) — Other (616 ) (112 ) 604 48 (76 ) Total other income (expense) 17,208 1,955 452 (613 ) 19,002 Income (loss) before income taxes (12,848 ) 16,889 (17,683 ) 535 (13,107 ) Income tax benefit — — (259 ) — (259 ) Net income (loss) $ (12,848 ) $ 16,889 $ (17,424 ) $ 535 $ (12,848 ) Comprehensive income (loss) $ (12,848 ) $ 16,889 $ (19,000 ) $ 535 $ (14,424 )
Supplemental condensed consolidating balance sheet	Globalstar, Inc. Condensed Consolidating Balance Sheet As of June 30, 2017 (Unaudited) Parent Company Guarantor Subsidiaries Non-Guarantor Subsidiaries Eliminations Consolidated (In thousands) ASSETS Current assets: Cash and cash equivalents $ 4,538 $ 1,975 $ 2,325 $ — $ 8,838 Accounts receivable 5,806 6,135 3,428 — 15,369 Intercompany receivables 938,139 717,066 46,098 (1,701,303 ) — Inventory 2,208 4,621 1,985 — 8,814 Prepaid expenses and other current assets 1,738 1,830 1,621 — 5,189 Total current assets 952,429 731,627 55,457 (1,701,303 ) 38,210 Property and equipment, net 1,005,671 3,751 4,371 5 1,013,798 Restricted cash 37,915 — — — 37,915 Intercompany notes receivable 7,447 — 6,436 (13,883 ) — Investment in subsidiaries (282,248 ) 78,753 37,502 165,993 — Intangible and other assets, net 17,321 87 2,650 (12 ) 20,046 Total assets $ 1,738,535 $ 814,218 $ 106,416 $ (1,549,200 ) $ 1,109,969 LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Current portion of long-term debt $ 108,720 $ — $ — $ — $ 108,720 Accounts payable 2,925 3,487 1,212 — 7,624 Accrued contract termination charge 20,026 — — — 20,026 Accrued expenses 7,713 6,097 6,854 — 20,664 Derivative Liabilities 36,860 — — — 36,860 Intercompany payables 673,426 773,216 254,622 (1,701,264 ) — Payables to affiliates 304 — — — 304 Deferred revenue 1,130 21,247 7,099 — 29,476 Total current liabilities 851,104 804,047 269,787 (1,701,264 ) 223,674 Long-term debt, less current portion 459,966 — — — 459,966 Employee benefit obligations 4,944 — — — 4,944 Intercompany notes payable 6,436 — 7,447 (13,883 ) — Derivative liabilities 318,215 — — — 318,215 Deferred revenue 5,468 384 14 — 5,866 Other non-current liabilities 928 325 4,577 — 5,830 Total non-current liabilities 795,957 709 12,038 (13,883 ) 794,821 Stockholders’ equity (deficit) 91,474 9,462 (175,409 ) 165,947 91,474 Total liabilities and stockholders’ equity $ 1,738,535 $ 814,218 $ 106,416 $ (1,549,200 ) $ 1,109,969 Globalstar, Inc. Condensed Consolidating Balance Sheet As of December 31, 2016 (Unaudited) Parent Company Guarantor Subsidiaries Non-Guarantor Subsidiaries Eliminations Consolidated (In thousands) ASSETS Current assets: Cash and cash equivalents $ 7,259 $ 1,327 $ 1,644 $ — $ 10,230 Accounts receivable 5,938 6,340 2,941 — 15,219 Intercompany receivables 897,691 678,707 32,040 (1,608,438 ) — Inventory 2,266 4,354 1,473 — 8,093 Prepaid expenses and other current assets 1,570 955 2,063 — 4,588 Total current assets 914,724 691,683 40,161 (1,608,438 ) 38,130 Property and equipment, net 1,031,623 3,708 4,384 4 1,039,719 Restricted cash 37,983 — — — 37,983 Intercompany notes receivable 8,901 — 6,436 (15,337 ) — Investment in subsidiaries (280,557 ) 73,029 36,146 171,382 — Intangible and other assets, net 15,259 128 1,407 (12 ) 16,782 Total assets $ 1,727,933 $ 768,548 $ 88,534 $ (1,452,401 ) $ 1,132,614 LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Current portion of long-term debt $ 75,755 $ — $ — $ — $ 75,755 Debt restructuring fees 20,795 — — — 20,795 Accounts payable 2,624 3,490 1,385 — 7,499 Accrued contract termination charge 18,451 — — — 18,451 Accrued expenses 10,573 5,884 6,705 — 23,162 Intercompany payables 636,336 750,084 221,980 (1,608,400 ) — Payables to affiliates 309 — — — 309 Deferred revenue 1,576 19,304 5,599 — 26,479 Total current liabilities 766,419 778,762 235,669 (1,608,400 ) 172,450 Long-term debt, less current portion 500,524 — — — 500,524 Employee benefit obligations 4,883 — — — 4,883 Intercompany notes payable 6,435 — 8,901 (15,336 ) — Derivative liabilities 281,171 — — — 281,171 Deferred revenue 5,567 299 11 — 5,877 Other non-current liabilities 1,115 325 4,450 — 5,890 Total non-current liabilities 799,695 624 13,362 (15,336 ) 798,345 Stockholders’ equity (deficit) 161,819 (10,838 ) (160,497 ) 171,335 161,819 Total liabilities and stockholders’ equity $ 1,727,933 $ 768,548 $ 88,534 $ (1,452,401 ) $ 1,132,614
Supplemental condensed consolidating statement of cash flows	Globalstar, Inc. Condensed Consolidating Statement of Cash Flows Six Months Ended June 30, 2017 (Unaudited) Parent Company Guarantor Subsidiaries Non- Guarantor Subsidiaries Eliminations Consolidated (In thousands) Cash flows provided by operating activities $ 4,008 $ 1,068 $ 1,180 $ — $ 6,256 Cash flows used in investing activities: Second-generation network costs (including interest) (6,498 ) — (32 ) — (6,530 ) Property and equipment additions (1,637 ) (420 ) (59 ) — (2,116 ) Purchase of intangible assets (1,552 ) — (492 ) — (2,044 ) Net cash used in investing activities (9,687 ) (420 ) (583 ) — (10,690 ) Cash flows provided by (used in) financing activities: Principal payments of the Facility Agreement (21,695 ) — — — (21,695 ) Proceeds from Thermo Common Stock Purchase Agreement 33,000 — — — 33,000 Payment of debt restructuring fee (20,795 ) — — — (20,795 ) Payment of debt amendment fee (255 ) — — — (255 ) Proceeds from issuance of stock to Terrapin 12,000 — — — 12,000 Proceeds from issuance of common stock and exercise of options and warrants 635 — — — 635 Net cash provided by financing activities 2,890 — — — 2,890 Effect of exchange rate changes on cash — — 84 — 84 Net increase (decrease) in cash, cash equivalents and restricted cash (2,789 ) 648 681 — (1,460 ) Cash, cash equivalents and restricted cash, beginning of period 45,242 1,327 1,644 — 48,213 Cash, cash equivalents and restricted cash, end of period $ 42,453 $ 1,975 $ 2,325 $ — $ 46,753 Globalstar, Inc. Condensed Consolidating Statement of Cash Flows Six Months Ended June 30, 2016 (Unaudited) Parent Company Guarantor Subsidiaries Non- Guarantor Subsidiaries Eliminations Consolidated (In thousands) Cash flows provided by (used in) operating activities $ 916 $ 255 $ (170 ) $ — $ 1,001 Cash flows used in investing activities: Second-generation network costs (including interest) (5,161 ) — (146 ) — (5,307 ) Property and equipment additions (5,937 ) (167 ) (241 ) — (6,345 ) Purchase of intangible assets (806 ) — — — (806 ) Net cash used in investing activities (11,904 ) (167 ) (387 ) — (12,458 ) Cash flows provided by (used in) financing activities: Principal payments of the Facility Agreement (16,418 ) — — — (16,418 ) Proceeds from issuance of stock to Terrapin 28,500 — — — 28,500 Proceeds from issuance of common stock and exercise of options and warrants 3,016 — — — 3,016 Net cash provided by financing activities 15,098 — — — 15,098 Effect of exchange rate changes on cash — — 152 — 152 Net increase (decrease) in cash, cash equivalents and restricted cash 4,110 88 (405 ) — 3,793 Cash, cash equivalents and restricted cash, beginning of period 41,448 719 3,227 — 45,394 Cash, cash equivalents and restricted cash, end of period $ 45,558 $ 807 $ 2,822 $ — $ 49,187

Property and Equipment - Schedu

Property and Equipment - Schedule of Property and Equipment (Details) - USD ($) $ in Thousands	Jun. 30, 2017	Dec. 31, 2016
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 1,555,875	$ 1,558,844
Accumulated depreciation	(542,077)	(519,125)
Total property and equipment, net	1,013,798	1,039,719
Internally developed and purchased software
Property, Plant and Equipment [Line Items]
Property and equipment, gross	16,530	15,005
Equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	10,153	9,875
Land and buildings
Property, Plant and Equipment [Line Items]
Property and equipment, gross	3,319	3,330
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	1,940	1,893
Globalstar System
Property, Plant and Equipment [Line Items]
Property and equipment, gross	1,523,933	1,528,741
Globalstar System | Ground component
Property, Plant and Equipment [Line Items]
Property and equipment, gross	48,562	48,400
Globalstar System | First and second-generation satellites in service | Space component
Property, Plant and Equipment [Line Items]
Property and equipment, gross	1,195,180	1,211,090
Globalstar System | Prepaid long-lead items | Space component
Property, Plant and Equipment [Line Items]
Property and equipment, gross	17,040	17,040
Globalstar System | Second-generation satellite, on-ground spare | Space component
Property, Plant and Equipment [Line Items]
Property and equipment, gross	32,481	32,481
Globalstar System | Construction in progress | Space component
Property, Plant and Equipment [Line Items]
Property and equipment, gross	463	81
Globalstar System | Construction in progress | Ground component
Property, Plant and Equipment [Line Items]
Property and equipment, gross	217,199	207,127
Globalstar System | Construction in progress | Next-generation software upgrades
Property, Plant and Equipment [Line Items]
Property and equipment, gross	11,091	10,223
Globalstar System | Construction in progress | Other
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 1,917	$ 2,299

Property and Equipment - Narrat

Property and Equipment - Narrative (Details) € in Millions	1 Months Ended
	Jun. 30, 2009EUR (€)
Property, Plant and Equipment [Abstract]
Payments to acquire machinery and equipment (in euros)	€ 12
Payments for construction in process (in euros)	€ 3.1

Long-Term Debt and Other Fina24

Long-Term Debt and Other Financing Arrangements - Schedule of Long-term Debt (Details) - USD ($) $ in Thousands	Jun. 30, 2017	Dec. 31, 2016	Dec. 31, 2013
Principal Amount
Total Debt	$ 638,412	$ 654,099
Less: Current Portion	110,313	75,755
Long-Term Debt	528,099	578,344
Unamortized Discount and Deferred Financing Costs
Unamortized Discount and Deferred Financing Costs	69,726	77,820
Current Unamortized Discount and Deferred Financing Costs	1,593
Noncurrent Unamortized Discount and Deferred Financing Costs	68,133	77,820
Carrying Value
Total Debt	568,686	576,279
Less: Current Portion	108,720	75,755
Long-term debt, less current portion	459,966	500,524
Facility Agreement
Principal Amount
Total Debt	521,317	543,011
Unamortized Discount and Deferred Financing Costs
Unamortized Discount and Deferred Financing Costs	40,098	45,651
Carrying Value
Total Debt	481,219	497,360
Thermo Loan Agreement
Principal Amount
Total Debt	99,776	93,962
Unamortized Discount and Deferred Financing Costs
Unamortized Discount and Deferred Financing Costs	28,035	29,615
Carrying Value
Total Debt	$ 71,741	64,347
8.00% Convertible Senior Notes Issued in 2013
Debt Instrument [Line Items]
Loan interest rate	8.00%		8.00%
Principal Amount
Total Debt	$ 17,319	17,126
Unamortized Discount and Deferred Financing Costs
Unamortized Discount and Deferred Financing Costs	1,593	2,554
Carrying Value
Total Debt	$ 15,726	$ 14,572

Long-Term Debt and Other Fina25

Long-Term Debt and Other Financing Arrangements - Facility Agreement (Details) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended	6 Months Ended
	Jan. 31, 2017	Jun. 30, 2017	Jun. 30, 2017	Jun. 30, 2016	Dec. 31, 2013	Jul. 31, 2013
Debt Instrument [Line Items]
Payments of debt restructuring costs and insurance premiums			$ 20,795	$ 0
Facility Agreement
Debt Instrument [Line Items]
Interest above LIBOR rate			2.75%
Percentage of guarantee provided by French export credit agency to lending syndicate			95.00%
Debt service reserve account		$ 37,900	$ 37,900			$ 37,900
Facility Agreement | Domestic Subsidiaries
Debt Instrument [Line Items]
Percentage of equity pledged as collateral		100.00%	100.00%
Facility Agreement | Foreign Subsidiaries
Debt Instrument [Line Items]
Percentage of equity pledged as collateral		65.00%	65.00%
Facility Agreement | Minimum
Debt Instrument [Line Items]
Interest rate increase			0.50%
Facility Agreement | Maximum
Debt Instrument [Line Items]
Interest rate increase			5.75%
8.00% Convertible Senior Notes Issued in 2013
Debt Instrument [Line Items]
Loan interest rate		8.00%	8.00%		8.00%
Thermo
Debt Instrument [Line Items]
Stock purchase agreement, value of shares			$ 33,000
Thermo | 2017 GARA
Debt Instrument [Line Items]
Minimum value of equity proceeds required to be raised per terms of agreement			159,000
Required equity proceeds to be raised per terms of agreement by specified period			$ 33,000
Percentage of proceeds to be deposited			80.00%
Limit of capital expenditures per terms of agreement			$ 20,000
Limit of capital expenditures per terms of agreement as a percentage of equity proceeds			20.00%
Amendment fees			$ 255
Payments of debt restructuring costs and insurance premiums			$ 20,800
Terrapin
Debt Instrument [Line Items]
Proceeds from lines of credit	$ 12,000	$ 12,000

Long-Term Debt and Other Fina26

Long-Term Debt and Other Financing Arrangements - Thermo Loan Agreement (Details) - Thermo - USD ($) $ / shares in Units, shares in Millions, $ in Millions	Jun. 29, 2017	Jun. 30, 2017	Jun. 30, 2017
Debt Instrument [Line Items]
Stock purchase agreement, value of shares			$ 33
Sale of stock, number of shares issued in transaction (in shares)	17.8
Sale of stock, consideration received on transaction	$ 33
Purchase price per share (USD per shares)	$ 1.85
Percentage discount on closing price	10.00%
Thermo Loan Agreement
Debt Instrument [Line Items]
Loan interest rate		12.00%	12.00%
Maturity period after full payment of Facility Agreement			6 months
Outstanding interest		$ 56.3	$ 56.3
Debt instrument, convertible, stock price trigger (USD per share)		$ 2.13
Debt instrument, convertible, if-converted value in excess of principal		$ 190.7

Long-Term Debt and Other Fina27

Long-Term Debt and Other Financing Arrangements - 8.00% Convertible Senior Notes Issued in 2013 (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended	6 Months Ended	49 Months Ended
	Jun. 30, 2017	Jun. 30, 2017	Jun. 30, 2017	Dec. 31, 2013
Debt Instrument [Line Items]
Debt conversion, converted instrument, settlement period		40 days
8.00% Convertible Senior Notes Issued in 2013
Debt Instrument [Line Items]
Loan interest rate	8.00%	8.00%	8.00%	8.00%
Conversion price per share of common stock (USD per share)				$ 0.73
Interest rate, payable in cash				5.75%
Interest rate, payable in additional notes				2.25%
Debt conversion, converted instrument, amount			$ 39.4
Debt conversion, converted instrument, shares issued (in shares)			72,100,000
Conversions during period (in shares)	0	0
Debt instrument, convertible, stock price trigger (USD per share)	$ 2.13
Debt instrument, convertible, if-converted value in excess of principal	$ 33.1

Long-Term Debt and Other Fina28

Long-Term Debt and Other Financing Arrangements - Warrants Outstanding (Details) - Contingent Equity Agreement - $ / shares shares in Millions	1 Months Ended	6 Months Ended
	May 31, 2017	Jun. 30, 2017	Jun. 30, 2012
Class of Warrant or Right [Line Items]
Number of warrants issued (in shares)			41.5
Exercise price of warrants (USD per share)			$ 0.01
Expiration period		5 years
Warrants outstanding (in shares)		0
Thermo
Class of Warrant or Right [Line Items]
Number of shares issued (in shares)	24.6	41.5
Warrants outstanding (in shares)	24.6

Long-Term Debt and Other Fina29

Long-Term Debt and Other Financing Arrangements - Terrapin Opportunity, L.P. Common Stock Purchase Agreement (Details) - USD ($)	1 Months Ended		3 Months Ended	6 Months Ended		23 Months Ended
	Jan. 31, 2017	Aug. 31, 2015	Jun. 30, 2017	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017
Debt Instrument [Line Items]
Maximum value of shares required to be purchased per terms of stock purchase agreement		$ 75,000,000
Stock purchase agreement term		24 months
Proceeds from issuance of stock to Terrapin				$ 12,000,000	$ 28,500,000
Terrapin
Debt Instrument [Line Items]
Number of shares issued (in shares)	8,866,558					67,275,241
Proceeds from issuance of stock to Terrapin						$ 75,000,000
Proceeds from lines of credit	$ 12,000,000		$ 12,000,000

Derivatives - Schedule of Fair

Derivatives - Schedule of Fair Value of Derivative Instruments (Details) - USD ($) $ in Thousands	Jun. 30, 2017	Dec. 31, 2016
Derivative assets:
Total derivative assets	$ 1	$ 4
Derivative liabilities:
Derivative liabilities, non-current	(318,215)	(281,171)
Total derivative liabilities	(355,075)	(281,171)
Interest rate cap
Derivative assets:
Interest rate cap	1	4
Compound embedded derivative with the 2013 8.00% Notes
Derivative liabilities:
Derivative liabilities, non-current	(36,860)	(26,664)
Compound embedded derivative with the Thermo Loan Agreement
Derivative liabilities:
Derivative liabilities, non-current	$ (318,215)	$ (254,507)
Compound embedded derivative with the 2013 8.00% Notes
Derivatives, Fair Value [Line Items]
Loan interest rate	8.00%

Derivatives - Schedule of Deriv

Derivatives - Schedule of Derivative Gain (Loss) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Derivative Instruments, Gain (Loss) [Line Items]
Derivative gain (loss)	$ (77,130)	$ 40,499	$ (73,907)	$ 39,155
Interest rate cap
Derivative Instruments, Gain (Loss) [Line Items]
Derivative gain (loss)	(1)	(1)	(3)	(5)
Compound embedded derivative with the 2013 8.00% Notes
Derivative Instruments, Gain (Loss) [Line Items]
Derivative gain (loss)	(11,354)	5,335	(10,196)	5,783
Compound embedded derivative with the Thermo Loan Agreement
Derivative Instruments, Gain (Loss) [Line Items]
Derivative gain (loss)	$ (65,775)	$ 35,165	$ (63,708)	$ 33,377
Compound embedded derivative with the 2013 8.00% Notes
Derivative Instruments, Gain (Loss) [Line Items]
Loan interest rate	8.00%		8.00%

Derivatives - Narrative (Detail

Derivatives - Narrative (Details) $ in Millions	1 Months Ended
	Jun. 30, 2009USD ($)contract	Jun. 30, 2017	Dec. 31, 2013
8.00% Convertible Senior Notes Issued in 2013
Derivative [Line Items]
Loan interest rate		8.00%	8.00%
Interest rate cap
Derivative [Line Items]
Number of Interest rate cap agreements (in contracts) | contract	5
Maturity period	10 years
Interest rate cap | Six-month LIBOR Rate
Derivative [Line Items]
Base rate to be capped, should the Base Rate not exceed 6.50%	5.50%
Interest on outstanding amounts on the Facility Agreement	6.50%
Base rate to be lowered from LIBOR, should the base rate exceed 6.50%	1.00%
Fee for interest rate cap agreements | $	$ 12.4

Fair Value Measurements - Finan

Fair Value Measurements - Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) - USD ($) $ in Thousands	Jun. 30, 2017	Dec. 31, 2016
Fair value, measurements, recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	$ 1	$ 4
Total liabilities measured at fair value	(355,075)	(284,266)
Fair value, measurements, recurring | Liability for potential stock issuance to Hughes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value		(2,706)
Fair value, measurements, recurring | Liability for stock issuance due to legal settlement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value		(389)
Fair value, measurements, recurring | Interest rate cap
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	1	4
Fair value, measurements, recurring | Compound embedded derivative with the 2013 8.00% Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value	(36,860)	(26,664)
Fair value, measurements, recurring | Compound embedded derivative with the Thermo Loan Agreement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value	(318,215)	(254,507)
Fair value, measurements, recurring | (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	0	0
Total liabilities measured at fair value	0	0
Fair value, measurements, recurring | (Level 1) | Liability for potential stock issuance to Hughes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value		0
Fair value, measurements, recurring | (Level 1) | Liability for stock issuance due to legal settlement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value		0
Fair value, measurements, recurring | (Level 1) | Interest rate cap
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	0	0
Fair value, measurements, recurring | (Level 1) | Compound embedded derivative with the 2013 8.00% Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value	0	0
Fair value, measurements, recurring | (Level 1) | Compound embedded derivative with the Thermo Loan Agreement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value	0	0
Fair value, measurements, recurring | (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	1	4
Total liabilities measured at fair value	0	(3,095)
Fair value, measurements, recurring | (Level 2) | Liability for potential stock issuance to Hughes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value		(2,706)
Fair value, measurements, recurring | (Level 2) | Liability for stock issuance due to legal settlement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value		(389)
Fair value, measurements, recurring | (Level 2) | Interest rate cap
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	1	4
Fair value, measurements, recurring | (Level 2) | Compound embedded derivative with the 2013 8.00% Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value	0	0
Fair value, measurements, recurring | (Level 2) | Compound embedded derivative with the Thermo Loan Agreement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value	0	0
Fair value, measurements, recurring | (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value	(355,075)	(281,171)
Fair value, measurements, recurring | (Level 3) | Liability for potential stock issuance to Hughes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value		0
Fair value, measurements, recurring | (Level 3) | Liability for stock issuance due to legal settlement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value		0
Fair value, measurements, recurring | (Level 3) | Interest rate cap
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	0	0
Fair value, measurements, recurring | (Level 3) | Compound embedded derivative with the 2013 8.00% Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value	(36,860)	(26,664)
Fair value, measurements, recurring | (Level 3) | Compound embedded derivative with the Thermo Loan Agreement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value	$ (318,215)	$ (254,507)
Compound embedded derivative with the 2013 8.00% Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loan interest rate	8.00%

Fair Value Measurements - Narra

Fair Value Measurements - Narrative (Details) shares in Millions, $ in Millions	1 Months Ended			6 Months Ended	12 Months Ended
	Mar. 31, 2017shares	Jun. 30, 2015USD ($)	Apr. 30, 2015USD ($)	Jun. 30, 2017contract	Dec. 31, 2016USD ($)shares	Dec. 31, 2013
Fair Value Measurements [Line Items]
Settlement amount					$ 0.4
Stock issued for settlement (in shares) | shares	0.3				1.3
Stock issuance settlement period				40 days
8.00% Convertible Senior Notes Issued in 2013
Fair Value Measurements [Line Items]
Loan interest rate				8.00%		8.00%
(Level 3)
Fair Value Measurements [Line Items]
Number of derivatives (in contracts) | contract				2
Hughes Network Systems LLC
Fair Value Measurements [Line Items]
Fair value of common stock issued to vendor for payment of invoices		$ 15.5	$ 15.5

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Significant Quantitative Level 3 Inputs Utilized (Details) - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2017	Dec. 31, 2016
Compound embedded derivative with the 2013 8.00% Notes
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Stock Price Volatility	90.00%
Risk-Free Interest Rate	1.20%	1.00%
Note Conversion Price (USD per share)	$ 0.73	$ 0.73
Discount Rate	26.00%	25.00%
Market Price of Common Stock (USD per share)	$ 2.13	$ 1.58
Compound embedded derivative with the 2013 8.00% Notes | Minimum
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Stock Price Volatility		100.00%
Compound embedded derivative with the 2013 8.00% Notes | Maximum
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Stock Price Volatility		110.00%
Compound embedded derivative with the Thermo Loan Agreement
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Risk-Free Interest Rate	2.00%	2.20%
Note Conversion Price (USD per share)	$ 0.73	$ 0.73
Discount Rate	26.00%	25.00%
Market Price of Common Stock (USD per share)	$ 2.13	$ 1.58
Compound embedded derivative with the Thermo Loan Agreement | Minimum
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Stock Price Volatility	40.00%	40.00%
Compound embedded derivative with the Thermo Loan Agreement | Maximum
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Stock Price Volatility	85.00%	110.00%
Compound embedded derivative with the 2013 8.00% Notes
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Loan interest rate	8.00%

Fair Value Measurements - Fair

Fair Value Measurements - Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at beginning of period	$ (277,946)	$ (240,982)	$ (281,171)	$ (239,642)
Unrealized gain (loss), included in derivative gain (loss)	(77,129)	40,500	(73,904)	39,160
Balance at end of period	$ (355,075)	$ (200,482)	$ (355,075)	$ (200,482)

Fair Value Measurements - Fai37

Fair Value Measurements - Fair Value and Carrying Value of Debt (Details) - USD ($) $ in Thousands	Jun. 30, 2017	Dec. 31, 2016	Dec. 31, 2013
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Carrying Value	$ 568,686	$ 576,279
Thermo Loan Agreement
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Carrying Value	71,741	64,347
Thermo Loan Agreement | Carrying Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Carrying Value	71,741	64,347
Thermo Loan Agreement | Estimated Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Estimated Fair Value	$ 51,045	47,874
8.00% Convertible Senior Notes Issued in 2013
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Loan interest rate	8.00%		8.00%
Carrying Value	$ 15,726	14,572
8.00% Convertible Senior Notes Issued in 2013 | Carrying Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Carrying Value	15,726	14,572
8.00% Convertible Senior Notes Issued in 2013 | Estimated Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Estimated Fair Value	$ 15,459	$ 14,350

Commitments and Contingencies (

Commitments and Contingencies (Details) $ in Thousands, € in Millions, BRL in Millions	Jun. 30, 2012EUR (€)	Jun. 24, 2012EUR (€)	May 10, 2012EUR (€)	Jun. 03, 2011satellite	Mar. 31, 2017USD ($)shares	Mar. 31, 2017BRLshares	Jun. 30, 2015USD ($)shares	Apr. 30, 2015USD ($)	Jun. 30, 2017USD ($)	Jun. 30, 2016USD ($)	Dec. 31, 2016USD ($)shares	Dec. 31, 2016EUR (€)shares	Dec. 31, 2016BRLshares
Commitments [Line Items]
Number of satellites (in satellites) | satellite				25
Issuance of common stock for legal settlement					$ 500	BRL 1.4			$ 453	$ 0	$ 1,400		BRL 4.5
Stock issued for settlement (in shares) | shares					300,000	300,000					1,300,000	1,300,000	1,300,000
Ericsson Inc.
Commitments [Line Items]
Purchase obligation due in next twelve months | $									$ 1,100
Hughes Network Systems LLC
Commitments [Line Items]
Percentage discount when paid In stock							7.00%	7.00%
Contract amount | $								$ 15,500
Share-based goods and nonemployee services transaction, quantity of securities issued (in shares) | shares							7,400,000
Fair value of common stock issued to vendor for payment of invoices | $							$ 15,500	$ 15,500
Thales Alenia Space
Commitments [Line Items]
Contract termination, damages awarded (in euros)			€ 51.3
Contract termination charge (in euros)	€ 17.5		€ 53									€ 17.5
Gain on release of liability (in euros)		€ 35.6
Accrued liability for legal settlement (in euros)		€ 17.5
Loss contingency accrual, percentage of termination charges		33.33%

Related Party Transactions - Na

Related Party Transactions - Narrative (Details) - USD ($) $ in Thousands, shares in Millions	1 Months Ended	3 Months Ended		6 Months Ended
	May 31, 2017	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016	Dec. 31, 2016
Related Party Transaction [Line Items]
Payables to affiliates		$ 304		$ 304		$ 309
Debt instrument, face amount		638,412		638,412		654,099
Derivative liabilities		(318,215)		(318,215)		(281,171)
Thermo Loan Agreement
Related Party Transaction [Line Items]
Debt instrument, face amount		$ 99,776		$ 99,776		93,962
Contingent Equity Agreement
Related Party Transaction [Line Items]
Warrants outstanding (in shares)		0		0
Compound embedded derivative with the Thermo Loan Agreement
Related Party Transaction [Line Items]
Derivative liabilities		$ (318,215)		$ (318,215)		$ (254,507)
Thermo
Related Party Transaction [Line Items]
Change in fair value related to equity issuance		200	$ 200	400	$ 300
Thermo | Contingent Equity Agreement
Related Party Transaction [Line Items]
Warrants outstanding (in shares)	24.6
Proceeds from warrant exercises	$ 200
Thermo | Compound embedded derivative with the Thermo Loan Agreement
Related Party Transaction [Line Items]
Interest expense, related party		$ 3,000	$ 2,600	$ 5,800	$ 5,200

Earnings (Loss) Per Share (Deta

Earnings (Loss) Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Net loss	$ (98,734)	$ 14,099	$ (118,895)	$ (12,848)
Effect of dilutive securities:
Income (loss) to common stockholders plus assumed conversions	$ (98,734)	$ 17,037	$ (118,895)	$ (12,848)
Weighted average common shares outstanding:
Basic shares outstanding (in shares)	1,128,985	1,049,381	1,121,518	1,045,205
Incremental shares from assumed exercises, conversions and other issuances:
Stock options, restricted stock, restricted stock units and ESPP (in shares)	0	5,793	0	0
Warrants and other (in shares)	0	27,625	0	0
Diluted shares outstanding (in shares)	1,128,985	1,249,672	1,121,518	1,045,205
Net income (loss) per common share:
Basic (USD per share)	$ (0.09)	$ 0.01	$ (0.11)	$ (0.01)
Diluted (USD per share)	$ (0.09)	$ 0.01	$ (0.11)	$ (0.01)
Antidilutive shares excluded from computation of earnings per share (in shares)	190,500		191,600	197,000
8.00% Convertible Senior Notes Issued in 2013
Effect of dilutive securities:
Dilutive securities	$ 0	$ 537	$ 0	$ 0
Incremental shares from assumed exercises, conversions and other issuances:
Conversion of debt securities (in shares)	0	27,164	0	0
Thermo Loan Agreement
Effect of dilutive securities:
Dilutive securities	$ 0	$ 2,401	$ 0	$ 0
Incremental shares from assumed exercises, conversions and other issuances:
Conversion of debt securities (in shares)	0	139,709	0	0

Condensed Consolidating Finan41

Condensed Consolidating Financial Information - Narrative (Details)	Jun. 30, 2017	Dec. 31, 2013
8.00% Convertible Senior Notes Issued in 2013
Condensed Financial Statements, Captions [Line Items]
Loan interest rate	8.00%	8.00%

Condensed Consolidating Stateme

Condensed Consolidating Statement of Operations (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Revenue:
Service revenues	$ 24,301	$ 20,970	$ 45,782	$ 39,719
Subscriber equipment sales	3,822	4,116	6,993	7,203
Total revenue	28,123	25,086	52,775	46,922
Operating expenses:
Cost of services (exclusive of depreciation, amortization, and accretion shown separately below)	9,036	7,937	18,010	15,528
Cost of subscriber equipment sales	2,778	2,886	4,874	5,064
Marketing, general and administrative	9,544	11,450	19,034	20,060
Depreciation, amortization and accretion	19,275	19,224	38,569	38,379
Total operating expenses	40,633	41,497	80,487	79,031
Loss from operations	(12,510)	(16,411)	(27,712)	(32,109)
Other income (expense):
Gain (loss) on equity issuance	1,964	(2,075)	2,670	(1,923)
Interest income and expense, net of amounts capitalized	(8,850)	(9,049)	(17,678)	(18,154)
Derivative gain (loss)	(77,130)	40,499	(73,907)	39,155
Equity in subsidiary earnings (loss)	0	0	0	0
Other	(2,102)	685	(2,126)	(76)
Total other income (expense)	(86,118)	30,060	(91,041)	19,002
Income (loss) before income taxes	(98,628)	13,649	(118,753)	(13,107)
Income tax expense (benefit)	106	(450)	142	(259)
Net income (loss)	(98,734)	14,099	(118,895)	(12,848)
Comprehensive income (loss)	(98,779)	13,174	(119,760)	(14,424)
Reportable Legal Entities | Parent Company
Revenue:
Service revenues	18,685	10,944	36,297	27,882
Subscriber equipment sales	60	96	127	424
Total revenue	18,745	11,040	36,424	28,306
Operating expenses:
Cost of services (exclusive of depreciation, amortization, and accretion shown separately below)	6,415	5,135	12,543	9,948
Cost of subscriber equipment sales	32	43	66	187
Marketing, general and administrative	5,312	5,430	10,971	10,604
Depreciation, amortization and accretion	19,101	18,851	38,052	37,623
Total operating expenses	30,860	29,459	61,632	58,362
Loss from operations	(12,115)	(18,419)	(25,208)	(30,056)
Other income (expense):
Gain (loss) on equity issuance	1,964	(2,075)	2,706	(1,923)
Interest income and expense, net of amounts capitalized	(8,829)	(9,000)	(17,584)	(17,981)
Derivative gain (loss)	(77,130)	40,499	(73,907)	39,155
Equity in subsidiary earnings (loss)	(1,282)	2,924	(3,215)	(1,427)
Other	(1,342)	170	(1,687)	(616)
Total other income (expense)	(86,619)	32,518	(93,687)	17,208
Income (loss) before income taxes	(98,734)	14,099	(118,895)	(12,848)
Income tax expense (benefit)	0	0	0	0
Net income (loss)	(98,734)	14,099	(118,895)	(12,848)
Comprehensive income (loss)	(98,734)	14,099	(118,895)	(12,848)
Reportable Legal Entities | Guarantor Subsidiaries
Revenue:
Service revenues	9,846	10,863	19,202	18,358
Subscriber equipment sales	3,702	2,774	5,993	4,466
Total revenue	13,548	13,637	25,195	22,824
Operating expenses:
Cost of services (exclusive of depreciation, amortization, and accretion shown separately below)	1,403	1,034	2,828	2,070
Cost of subscriber equipment sales	3,106	2,112	4,823	3,540
Marketing, general and administrative	997	1,322	2,116	1,854
Depreciation, amortization and accretion	120	206	402	426
Total operating expenses	5,626	4,674	10,169	7,890
Loss from operations	7,922	8,963	15,026	14,934
Other income (expense):
Gain (loss) on equity issuance	0	0	0	0
Interest income and expense, net of amounts capitalized	7	(3)	(1)	(12)
Derivative gain (loss)	0	0	0	0
Equity in subsidiary earnings (loss)	(4,076)	(968)	(7,510)	2,079
Other	(337)	92	(437)	(112)
Total other income (expense)	(4,406)	(879)	(7,948)	1,955
Income (loss) before income taxes	3,516	8,084	7,078	16,889
Income tax expense (benefit)	4	0	9	0
Net income (loss)	3,512	8,084	7,069	16,889
Comprehensive income (loss)	3,512	8,084	7,069	16,889
Reportable Legal Entities | Non- Guarantor Subsidiaries
Revenue:
Service revenues	13,096	10,689	24,097	20,114
Subscriber equipment sales	1,491	1,997	2,841	3,674
Total revenue	14,587	12,686	26,938	23,788
Operating expenses:
Cost of services (exclusive of depreciation, amortization, and accretion shown separately below)	1,974	2,702	5,147	5,597
Cost of subscriber equipment sales	1,525	1,478	1,952	2,693
Marketing, general and administrative	19,357	16,219	37,265	33,064
Depreciation, amortization and accretion	54	288	115	569
Total operating expenses	22,910	20,687	44,479	41,923
Loss from operations	(8,323)	(8,001)	(17,541)	(18,135)
Other income (expense):
Gain (loss) on equity issuance	0	0	(36)	0
Interest income and expense, net of amounts capitalized	(32)	(47)	(101)	(152)
Derivative gain (loss)	0	0	0	0
Equity in subsidiary earnings (loss)	0	0	0	0
Other	(418)	328	5	604
Total other income (expense)	(450)	281	(132)	452
Income (loss) before income taxes	(8,773)	(7,720)	(17,673)	(17,683)
Income tax expense (benefit)	102	(450)	133	(259)
Net income (loss)	(8,875)	(7,270)	(17,806)	(17,424)
Comprehensive income (loss)	(8,911)	(8,195)	(18,662)	(19,000)
Eliminations
Revenue:
Service revenues	(17,326)	(11,526)	(33,814)	(26,635)
Subscriber equipment sales	(1,431)	(751)	(1,968)	(1,361)
Total revenue	(18,757)	(12,277)	(35,782)	(27,996)
Operating expenses:
Cost of services (exclusive of depreciation, amortization, and accretion shown separately below)	(756)	(934)	(2,508)	(2,087)
Cost of subscriber equipment sales	(1,885)	(747)	(1,967)	(1,356)
Marketing, general and administrative	(16,122)	(11,521)	(31,318)	(25,462)
Depreciation, amortization and accretion	0	(121)	0	(239)
Total operating expenses	(18,763)	(13,323)	(35,793)	(29,144)
Loss from operations	6	1,046	11	1,148
Other income (expense):
Gain (loss) on equity issuance	0	0	0	0
Interest income and expense, net of amounts capitalized	4	1	8	(9)
Derivative gain (loss)	0	0	0	0
Equity in subsidiary earnings (loss)	5,358	(1,956)	10,725	(652)
Other	(5)	95	(7)	48
Total other income (expense)	5,357	(1,860)	10,726	(613)
Income (loss) before income taxes	5,363	(814)	10,737	535
Income tax expense (benefit)	0	0	0	0
Net income (loss)	5,363	(814)	10,737	535
Comprehensive income (loss)	$ 5,354	$ (814)	$ 10,728	$ 535

Condensed Consolidating Balance

Condensed Consolidating Balance Sheet (Details) - USD ($) $ in Thousands	Jun. 30, 2017	Dec. 31, 2016
Current assets:
Cash and cash equivalents	$ 8,838	$ 10,230
Accounts receivable	15,369	15,219
Intercompany receivables	0	0
Inventory	8,814	8,093
Prepaid expenses and other current assets	5,189	4,588
Total current assets	38,210	38,130
Property and equipment, net	1,013,798	1,039,719
Restricted cash	37,915	37,983
Intercompany notes receivable	0	0
Investment in subsidiaries	0	0
Intangible and other assets, net	20,046	16,782
Total assets	1,109,969	1,132,614
Current liabilities:
Current portion of long-term debt	108,720	75,755
Debt restructuring fees	0	20,795
Accounts payable	7,624	7,499
Accrued contract termination charge	20,026	18,451
Accrued expenses	20,664	23,162
Derivative liabilities	36,860	0
Intercompany payables	0	0
Payables to affiliates	304	309
Deferred revenue	29,476	26,479
Total current liabilities	223,674	172,450
Long-term debt, less current portion	459,966	500,524
Employee benefit obligations	4,944	4,883
Intercompany notes payable	0	0
Derivative liabilities	318,215	281,171
Deferred revenue	5,866	5,877
Other non-current liabilities	5,830	5,890
Total non-current liabilities	794,821	798,345
Stockholders’ equity (deficit)	91,474	161,819
Total liabilities and stockholders’ equity	1,109,969	1,132,614
Reportable Legal Entities | Parent Company
Current assets:
Cash and cash equivalents	4,538	7,259
Accounts receivable	5,806	5,938
Intercompany receivables	938,139	897,691
Inventory	2,208	2,266
Prepaid expenses and other current assets	1,738	1,570
Total current assets	952,429	914,724
Property and equipment, net	1,005,671	1,031,623
Restricted cash	37,915	37,983
Intercompany notes receivable	7,447	8,901
Investment in subsidiaries	(282,248)	(280,557)
Intangible and other assets, net	17,321	15,259
Total assets	1,738,535	1,727,933
Current liabilities:
Current portion of long-term debt	108,720	75,755
Debt restructuring fees		20,795
Accounts payable	2,925	2,624
Accrued contract termination charge	20,026	18,451
Accrued expenses	7,713	10,573
Derivative liabilities	36,860
Intercompany payables	673,426	636,336
Payables to affiliates	304	309
Deferred revenue	1,130	1,576
Total current liabilities	851,104	766,419
Long-term debt, less current portion	459,966	500,524
Employee benefit obligations	4,944	4,883
Intercompany notes payable	6,436	6,435
Derivative liabilities	318,215	281,171
Deferred revenue	5,468	5,567
Other non-current liabilities	928	1,115
Total non-current liabilities	795,957	799,695
Stockholders’ equity (deficit)	91,474	161,819
Total liabilities and stockholders’ equity	1,738,535	1,727,933
Reportable Legal Entities | Guarantor Subsidiaries
Current assets:
Cash and cash equivalents	1,975	1,327
Accounts receivable	6,135	6,340
Intercompany receivables	717,066	678,707
Inventory	4,621	4,354
Prepaid expenses and other current assets	1,830	955
Total current assets	731,627	691,683
Property and equipment, net	3,751	3,708
Restricted cash	0	0
Intercompany notes receivable	0	0
Investment in subsidiaries	78,753	73,029
Intangible and other assets, net	87	128
Total assets	814,218	768,548
Current liabilities:
Current portion of long-term debt	0	0
Debt restructuring fees		0
Accounts payable	3,487	3,490
Accrued contract termination charge	0	0
Accrued expenses	6,097	5,884
Derivative liabilities	0
Intercompany payables	773,216	750,084
Payables to affiliates	0	0
Deferred revenue	21,247	19,304
Total current liabilities	804,047	778,762
Long-term debt, less current portion	0	0
Employee benefit obligations	0	0
Intercompany notes payable	0	0
Derivative liabilities	0	0
Deferred revenue	384	299
Other non-current liabilities	325	325
Total non-current liabilities	709	624
Stockholders’ equity (deficit)	9,462	(10,838)
Total liabilities and stockholders’ equity	814,218	768,548
Reportable Legal Entities | Non- Guarantor Subsidiaries
Current assets:
Cash and cash equivalents	2,325	1,644
Accounts receivable	3,428	2,941
Intercompany receivables	46,098	32,040
Inventory	1,985	1,473
Prepaid expenses and other current assets	1,621	2,063
Total current assets	55,457	40,161
Property and equipment, net	4,371	4,384
Restricted cash	0	0
Intercompany notes receivable	6,436	6,436
Investment in subsidiaries	37,502	36,146
Intangible and other assets, net	2,650	1,407
Total assets	106,416	88,534
Current liabilities:
Current portion of long-term debt	0	0
Debt restructuring fees		0
Accounts payable	1,212	1,385
Accrued contract termination charge	0	0
Accrued expenses	6,854	6,705
Derivative liabilities	0
Intercompany payables	254,622	221,980
Payables to affiliates	0	0
Deferred revenue	7,099	5,599
Total current liabilities	269,787	235,669
Long-term debt, less current portion	0	0
Employee benefit obligations	0	0
Intercompany notes payable	7,447	8,901
Derivative liabilities	0	0
Deferred revenue	14	11
Other non-current liabilities	4,577	4,450
Total non-current liabilities	12,038	13,362
Stockholders’ equity (deficit)	(175,409)	(160,497)
Total liabilities and stockholders’ equity	106,416	88,534
Eliminations
Current assets:
Cash and cash equivalents	0	0
Accounts receivable	0	0
Intercompany receivables	(1,701,303)	(1,608,438)
Inventory	0	0
Prepaid expenses and other current assets	0	0
Total current assets	(1,701,303)	(1,608,438)
Property and equipment, net	5	4
Restricted cash	0	0
Intercompany notes receivable	(13,883)	(15,337)
Investment in subsidiaries	165,993	171,382
Intangible and other assets, net	(12)	(12)
Total assets	(1,549,200)	(1,452,401)
Current liabilities:
Current portion of long-term debt	0	0
Debt restructuring fees		0
Accounts payable	0	0
Accrued contract termination charge	0	0
Accrued expenses	0	0
Derivative liabilities	0
Intercompany payables	(1,701,264)	(1,608,400)
Payables to affiliates	0	0
Deferred revenue	0	0
Total current liabilities	(1,701,264)	(1,608,400)
Long-term debt, less current portion	0	0
Employee benefit obligations	0	0
Intercompany notes payable	(13,883)	(15,336)
Derivative liabilities	0	0
Deferred revenue	0	0
Other non-current liabilities	0	0
Total non-current liabilities	(13,883)	(15,336)
Stockholders’ equity (deficit)	165,947	171,335
Total liabilities and stockholders’ equity	$ (1,549,200)	$ (1,452,401)

Condensed Consolidating State44

Condensed Consolidating Statement of Cash Flows (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Condensed Financial Statements, Captions [Line Items]
Cash flows provided by operating activities	$ 6,256	$ 1,001
Cash flows used in investing activities:
Second-generation network costs (including interest)	(6,530)	(5,307)
Property and equipment additions	(2,116)	(6,345)
Purchase of intangible assets	(2,044)	(806)
Net cash used in investing activities	(10,690)	(12,458)
Cash flows provided by (used in) financing activities:
Principal payments of the Facility Agreement	(21,695)	(16,418)
Proceeds from Thermo Common Stock Purchase Agreement	33,000	0
Payment of debt restructuring fee	(20,795)	0
Payment of debt amendment fee	(255)	0
Proceeds from issuance of stock to Terrapin	12,000	28,500
Proceeds from issuance of common stock and exercise of options and warrants	635	3,016
Net cash provided by financing activities	2,890	15,098
Effect of exchange rate changes on cash	84	152
Net increase (decrease) in cash, cash equivalents and restricted cash	(1,460)	3,793
Cash, cash equivalents and restricted cash, beginning of period	48,213	45,394
Cash, cash equivalents and restricted cash, end of period	46,753	49,187
Reportable Legal Entities | Parent Company
Condensed Financial Statements, Captions [Line Items]
Cash flows provided by operating activities	4,008	916
Cash flows used in investing activities:
Second-generation network costs (including interest)	(6,498)	(5,161)
Property and equipment additions	(1,637)	(5,937)
Purchase of intangible assets	(1,552)	(806)
Net cash used in investing activities	(9,687)	(11,904)
Cash flows provided by (used in) financing activities:
Principal payments of the Facility Agreement	(21,695)	(16,418)
Proceeds from Thermo Common Stock Purchase Agreement	33,000
Payment of debt restructuring fee	(20,795)
Payment of debt amendment fee	(255)
Proceeds from issuance of stock to Terrapin	12,000	28,500
Proceeds from issuance of common stock and exercise of options and warrants	635	3,016
Net cash provided by financing activities	2,890	15,098
Effect of exchange rate changes on cash	0	0
Net increase (decrease) in cash, cash equivalents and restricted cash	(2,789)	4,110
Cash, cash equivalents and restricted cash, beginning of period	45,242	41,448
Cash, cash equivalents and restricted cash, end of period	42,453	45,558
Reportable Legal Entities | Guarantor Subsidiaries
Condensed Financial Statements, Captions [Line Items]
Cash flows provided by operating activities	1,068	255
Cash flows used in investing activities:
Second-generation network costs (including interest)	0	0
Property and equipment additions	(420)	(167)
Purchase of intangible assets	0	0
Net cash used in investing activities	(420)	(167)
Cash flows provided by (used in) financing activities:
Principal payments of the Facility Agreement	0	0
Proceeds from Thermo Common Stock Purchase Agreement	0
Payment of debt restructuring fee	0
Payment of debt amendment fee	0
Proceeds from issuance of stock to Terrapin	0	0
Proceeds from issuance of common stock and exercise of options and warrants	0	0
Net cash provided by financing activities	0	0
Effect of exchange rate changes on cash	0	0
Net increase (decrease) in cash, cash equivalents and restricted cash	648	88
Cash, cash equivalents and restricted cash, beginning of period	1,327	719
Cash, cash equivalents and restricted cash, end of period	1,975	807
Reportable Legal Entities | Non- Guarantor Subsidiaries
Condensed Financial Statements, Captions [Line Items]
Cash flows provided by operating activities	1,180	(170)
Cash flows used in investing activities:
Second-generation network costs (including interest)	(32)	(146)
Property and equipment additions	(59)	(241)
Purchase of intangible assets	(492)	0
Net cash used in investing activities	(583)	(387)
Cash flows provided by (used in) financing activities:
Principal payments of the Facility Agreement	0	0
Proceeds from Thermo Common Stock Purchase Agreement	0
Payment of debt restructuring fee	0
Payment of debt amendment fee	0
Proceeds from issuance of stock to Terrapin	0
Proceeds from issuance of common stock and exercise of options and warrants	0	0
Net cash provided by financing activities	0	0
Effect of exchange rate changes on cash	84	152
Net increase (decrease) in cash, cash equivalents and restricted cash	681	(405)
Cash, cash equivalents and restricted cash, beginning of period	1,644	3,227
Cash, cash equivalents and restricted cash, end of period	2,325	2,822
Eliminations
Condensed Financial Statements, Captions [Line Items]
Cash flows provided by operating activities	0	0
Cash flows used in investing activities:
Second-generation network costs (including interest)	0	0
Property and equipment additions	0	0
Purchase of intangible assets	0	0
Net cash used in investing activities	0	0
Cash flows provided by (used in) financing activities:
Principal payments of the Facility Agreement	0	0
Proceeds from Thermo Common Stock Purchase Agreement	0
Payment of debt restructuring fee	0
Payment of debt amendment fee	0
Proceeds from issuance of stock to Terrapin	0	0
Proceeds from issuance of common stock and exercise of options and warrants	0	0
Net cash provided by financing activities	0	0
Effect of exchange rate changes on cash	0	0
Net increase (decrease) in cash, cash equivalents and restricted cash	0	0
Cash, cash equivalents and restricted cash, beginning of period	0	0
Cash, cash equivalents and restricted cash, end of period	$ 0	$ 0

Uncategorized Items - gsat-2017

Label	Element	Value
Restricted Cash	us-gaap_RestrictedCash	$ 37,983,000
Restricted Cash	us-gaap_RestrictedCash	$ 37,915,000